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Abstract 
Ischaemia-reperfusion injury (IRI) is the major cause of acute kidney injury (AKI) and 
predisposes to the development of chronic kidney disease (CKD). The role of TGF-β 
in extracellular matrix deposition and renal fibrosis has been well established. This 
study was designed to establish an in vitro model of renal tubular IRI, evaluate the 
role of TGF-β in IRI in human proximal tubular epithelial cells (HKC8 and HK2 cells) 
and further determine the role of αvβ6 integrin in IRI. Initially an in vitro model of 
hypoxia and free radical stress by treating HKC8, HK2 and fibroblasts (MRC-5 cells) 
with CoCl2 and H2O2 respectively was established. These treatments led to pro-
fibrotic changes characterised by increased expression of fibrotic marker α-SMA and 
reduced expression of epithelial cell marker E-Cadherin at mRNA and protein level. 
Binding of TGF-β to its receptor leads to activation of the kinase ALK5. ALK5 
inhibition prevented the changes induced by H2O2 or CoCl2 suggesting the 
involvement of TGF-β to the cellular response to IRI. To confirm that TGF-β is 
released after treatment of cells to mimic IRI, media transfer and co-culture studies 
were performed. These experiments confirmed that bioactive TGF-β was being 
released. Lastly, the role of αvβ6 integrin was studied post H2O2 or CoCl2 treatment. 
Expression of αvβ6 integrin was elevated in conditions mimicking IRI in vitro and in 
biopsy samples acquired from patients with acute tubular necrosis and in mouse 
kidney following IRI. Knockdown of αvβ6 integrin in HKC8 cells decreased the 
bioavailability of active TGF-β following CoCl2 or H2O2 treatment and therefore the 
pro-fibrotic changes that were seen. This study confirms that bioactive TGF-β is 
produced following IRI and αvβ6 plays an important role in its release. 
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Chapter 1: Introduction 
1.1 The kidney and its function 
1.1.1 Anatomy of Kidney 
The human kidneys, each weighing around 150 grams, are positioned outside the 
peritoneal cavity on either side of the spine; with the right kidney usually lower than 
the left. They account for 2% of human body weight but receive 25% of cardiac 
output.  They consists of a reddish brown cortex surrounding a pale striped cone 
shaped region, the medulla, and a pelvis that joins with the ureter (Ghori et al., 2016). 
1.1.2 The Functional Unit of Kidney: The Nephron 
The nephron is the basic functional unit of the kidney, comprising a glomerular 
capillary network that is surrounded by Bowman’s capsule that further connects to a 
system of tubules transporting filtrate to the collecting duct. Each kidney comprises of 
around one million nephrons. Based on location of the renal corpuscle and the length 
of the loop of Henle, nephrons are classified into cortical and juxtamedullary 
nephrons. The barrier between capillary blood and urine is maintained by specialised 
endothelial cells, the glomerular basement membrane and epithelial podocytes which 
allow selective ultrafiltration based on size and charge. Once the filtrate crosses 
glomerulus, it reaches the tubules for further reabsorption and secretion (Rayner et 
al., 2016). The tubules are lined by single layer of cells and vary from 4cm to 8cm in 
length. Tubules are subdivided into proximal tubule, loop of Henle, distal tubule and 
collecting duct based on cell structure, function and localisation along the nephron. 
The presence of cellular microvilli/brush border in this segment delivers increased 
surface area that facilitates maximum reabsorption (Rashid and Schwartz, 2012). 
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1.1.3 Function of the Kidney 
The kidney plays a vital role in maintaining pH homeostasis and electrolyte balance 
in blood.  This is achieved by reabsorption of water, salts, glucose and amino acids 
by active and passive transport along each segment of nephron. They also facilitate 
the removal of organic molecules, drugs and nitrogenous waste products such as 
urea and ammonium from the body. The kidneys produce erythropoietin and renin, 
and are also involved in the Vitamin D metabolism (Rizzo, 2015). 
1.2 Acute and Chronic Kidney Disease 
Acute kidney injury (AKI) is characterised by a rapid loss in renal excretory function, 
resulting accumulation of products of nitrogen metabolism such as creatinine and 
urea and other clinically unmeasured waste products, electrolytes and fluid (Bellomo 
et al., 2012). Other common clinical and laboratory manifestations include decreased 
urine output (not always present), accumulation of metabolic acids, and increased 
potassium and phosphate concentrations, reduced immunity and dysfunction of non-
renal organs (Ostermann and Joannidis, 2016).  
1.2.1 Epidemiology of Acute Kidney Injury 
The kidney is susceptible to a range of diseases that cause an acute decline in the 
filtration function. AKI is a global public health problem which it is associated with an 
increased risk of mortality, up to 50–80% in critically ill patients requiring renal 
replacement therapy (Molitoris et al., 2007; Ftouh and Thomas, 2013).It is 
challenging to ascertain an accurate figure for the incidence of AKI. Studies relying 
on medical data suggest an incidence of 486-630 per million populations per year 
which tends to increase drastically with age and is more prevalent in males and black 
populations (Kilbride). AKI can affect 13% to 18% of critically ill patients admitted to 
hospital in developed countries (Thomas et al., 2013). The incidence of AKI is greater 
than 60% amongst patients during intensive care unit admission (Hoste and 
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Schurgers, 2008). Furthermore, the annual cost to the NHS of AKI in secondary care 
is projected between £434-630 million, which is higher than the cost linked with 
breast, lung and skin cancer together (Anathhanam and Lewington, 2012). 
Geographical location might affect the causes of AKI. Cardiac surgery and sepsis are 
common in developed countries while dehydration is common in developing 
countries (Bagshaw et al., 2008). Around 2 million deaths occur annually due to AKI 
worldwide (Murugan and Kellum, 2011). 
1.2.2 Aetiology 
The condition that causes AKI can be broadly divided into 3 groups pre-renal, 
intrinsic and post-renal (Figure 1.1).  
In pre-renal AKI, the functional integrity of kidney is preserved but glomerular and 
renal perfusion is decreased. It most commonly occurs in older patients with 
concurrent illness. In such patients, the glomerular filtration rate decreases as the 
mean arterial pressure falls. Loss of blood, dehydration, vomiting and nausea may 
also contribute to a fall in filtration rate. The use of certain anti-inflammatory drugs 
and antihypertensive that reduce the activity of angiotensin system also predispose 
to AKI (Abuelo, 2007; Kanbay et al., 2010).  
Intrinsic AKI can be categorised by the region of the kidney primarily affected 
(tubular, glomerular, interstitial or vascular). Acute tubular necrosis (ATN) is a type of 
intrinsic AKI predominant among hospitalised patients. It usually occurs due to 
prolonged ischaemia or exposure to nephrotoxic agents that damage the tubular 
cells. AKI from glomerular damage is most frequently a result of acute inflammation 
(Rahman et al., 2012). In these conditions, the use of renal biopsy or imaging is often 
required to confirm the diagnosis before commencing therapy (Singer et al., 2011). 
Post-renal AKI occurs in patients due to obstruction of urinary flow (Basile et al., 
2012).  
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Figure 1.1 Potential causes of AKI.  
 
1.2.3 Pathophysiology of Acute Kidney Injury 
Adequate supply of oxygenated blood is necessary for production of mitochondrial 
adenosine triphosphate (ATP) and homeostatic cell function. The initiation phase of 
ischaemic AKI occurs when renal blood flow decreases. Lack of oxygen induces 
structural and functional changes in proximal tubular epithelial cells, disrupting their 
ability to maintain normal renal function (Sutton et al., 2002).The extension phase of 
AKI is mediated by prolonged hypoxia after the initial ischaemic event and an 
inflammatory response (Devarajan, 2006). This is followed by the maintenance 
phase as cells attempt to maintain cellular and tubular integrity by undergoing repair, 
dedifferentiation, migration, apoptosis and proliferation (Dirkes, 2015). In order to 
restore structural and functional integrity of a nephron, tubular repair mechanisms are 
initiated. During recovery phase, differentiation of cells continues and epithelial cell 
polarity is re-established to restore cellular and organ function (Nony and 
Schnellmann, 2003; Schrier et al., 2004) (Figure 1.2).          
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Figure 1.2 Pathophysiology of AKI. Stages of ischemic acute kidney injury 
depicting the relationship between the clinical phases and the cellular phases of AKI, 
and the temporal impact on organ function as represented by the GFR. Adapted  
from (Basile et al., 2012). 
 
1.2.4 Early consequences of Acute Kidney Injury 
AKI affects upto 15% of hospitalised patients; it is strongly associated with increased 
morbidity, mortality and cost. Patients with AKI are unable to control volume status, 
serum biochemistry and acid base balance. Less severe forms can be managed with 
supportive care, but more severe forms require renal replacement therapy.  Previous 
studies have shown an increased mortality in critically ill patients requiring dialysis 
(Lafrance and Miller, 2010; Hoste and De Corte, 2012).   
1.2.5 AKI leading to Chronic Kidney disease 
The severity of AKI, reversibility of the injury, temporal balance among effective and 
maladaptive repair and regenerative mechanisms define the course of renal disease 
after an episode of AKI. An observational study showed that the risk of developing 
stage 4 or 5 CKD was 28 times higher among patients with AKI necessitating dialysis 
(Waikar et al., 2006). Furthermore, the risk of developing End Stage Renal Disease 
(ESRD) was 40 times higher in patients that had both AKI and pre-existing CKD 
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(Chawla et al., 2014). Recent clinical findings suggest that a single episode of AKI 
causes irreversible renal damage and these patients have a significant risk for 
progression to CKD in future with or without coexisting conditions such as 
hypertension, diabetes, or cardiovascular disease (Coca et al., 2009; Garg and 
Parikh, 2009).  
Although healthy regeneration after AKI should lead to recovery of normal structure 
and function, maladaptive repair processes associated with dysregulated apoptosis, 
hypoxia, myofibroblast proliferation and infiltrating immune cells can lead to the loss 
of nephrons and progression to CKD via a self-perpetuating tubulo-interstitial fibrosis 
pathway. (Chawla and Kimmel, 2012; Chawla et al., 2014). It is noteworthy that 
pathology seen in other forms of CKD is indistinguishable from the changes that 
develop in tubulo-interstitial fibrosis after ischaemic AKI .In addition to clinical 
findings, data from experimental models of AKI provide insight into biological 
mechanisms by which AKI contributes to subsequent CKD (Chawla and Kimmel, 
2012). Studies have shown that a variety of intrinsic repair processes are activated 
rapidly after kidney injury induced by several pathophysiological processes such as 
hypoxia, oxidative stress, epigenetic changes, cell cycle arrest, DNA damage 
response, and mitochondrial dysfunction (Humphreys et al., 2008). These events 
initiate an uncontrolled maladaptive repair mechanism that leads to interstitial fibrosis 
(Basile et al., 2015).  Furthermore, the expansion or maintenance of injury–induced 
interstitial changes may be driven by profibrotic factors such as TGF-β, connective 
tissue growth factor, and platelet–derived growth factor-B produced by stressed 
tubular epithelial cells and infiltrating cells (Venkatachalam et al., 2010; Yang et al., 
2010b).   
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1.2.6 Chronic Kidney Disease 
Chronic kidney disease is common and associated with an increased risk of end 
stage kidney disease and a requirement of dialysis and transplantation. In the clinic, 
CKD is diagnosed when structural or functional abnormalities of the renal tract are 
present. Functional abnormalities are defined as either a reduced GFR (<60mL/min 
per 1.73m2) or albuminuria/haematuria (Jha et al., 2013).  In many countries, the 
incidence of CKD is as high as 200 cases per million per year (Levey et al., 2005).  
Over the past decade, the number of patients diagnosed with ESRD in the UK has 
doubled, thereby increasing the cost of providing renal replacement therapy (RRT) in 
the form of either dialysis or transplantation (Aitken et al., 2014). In 2014, the number 
of new patients requiring RRT was 7,411 in the UK, with a rate of ESRD of 115 pmp 
(Gilg et al., 2016). The incidence rate is higher in men than women. This increase in 
incidence of ESRD is expected to continue to rise at an annual rate of around 5–8% 
due to 2 factors (Renal, 2014). Firstly, the risk of developing CKD is higher among 
patients over 65 years and secondly, the number of patients suffering from diabetes 
and cardiovascular disease has risen in the last 20 years (Zoccali et al., 2010).   
1.2.7 Classification of stages of CKD 
According to K/DOQI guidelines, GFR is used to assess the severity of CKD and 
based on GFR and albuminuria CKD is categorized in 5 main stages (Table 1.1).  
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Table 1.1: Stages of CKD. The risk for progression of CKD is determined by colors 
according to the National Kidney Foundation’s Kidney Disease Outcomes Quality 
Initiative (KDOQI) classification system (Inker et al., 2014). 
 
1.2.8 Management of CKD 
In the last 10 years, research into CKD has intensified focusing on the prevention, 
early detection and treatment before it progresses towards renal failure  (Jha et al., 
2013).  
The risk factors associated with CKD such as diabetes, obesity and hypertension are 
becoming more prevalent among patients in UK (Stevens et al., 2012). Appropriate 
treatment should be offered to patients to avoid complications. Randomised control 
trials suggest angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-
receptor blockers are the first line treatment for patients to reduce proteinuria and 
slow disease progression. Antihypertensive drugs along with ACE inhibitors are 
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administered to patients to reduce blood pressure (less than 130/80mm Hg) which 
slows progression of CKD (Cohn and Tognoni, 2001). 
1.3 Ischaemia and Reperfusion Injury (IRI) 
1.3.1 Ischaemia 
An adequate supply of oxygen is critical to renal cell aerobic metabolism, 
maintenance of high-energy stores and normal renal function. Since the proximal 
tubule of the nephron has high oxygen consumption, ischaemia primarily influences 
structure and function of tubular epithelial cells in this region of the kidney. A 
mismatch of oxygen supply and local tissue demand causes certain cells irreversible 
cell damage which will eventually lead to cell death (Carden and Granger, 2000; De 
Groot and Rauen, 2007).  
Prolonged deprivation of oxygen inhibits mitochondrial oxidative phosphorylation. 
This leads to rapid dissociation of ATP molecules to Adenosine monophosphate 
which may be further metabolised to adenosine and hypoxanthine. ATP depletion 
leads to rise in intracellular calcium concentration causing activation of proteases and 
phospholipases and cytoskeletal degradation (De Rosa et al., 2017). Ischaemia 
induces production of inducible form of nitric oxide synthase (iNOS) that mediates 
production of high concentration of toxic nitric oxide (NO) from nitrate in proximal 
tubular epithelial cells (Goligorsky et al., 2002). Generation of nitric oxide in ischemic 
phase results in formation of a cytotoxic metabolite, peroxynitrite, which can cause 
lipid peroxidation and nitrotyrosine modification (Devarajan, 2006). Studies have 
suggested that increased NO via iNOS activity during renal ischemia is deleterious to 
the kidney and inhibition of iNOS before IRI protects kidneys against IRI (Devarajan, 
2005).  
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1.3.1.1 Hypoxia Inducible factor (HIF) 
In an event of hypoxia, cells respond by increasing transcription of genes involved in 
in angiogenesis, erythropoiesis and anaerobic energy metabolism. Erythropoietin 
(EPO) maintains the oxygen carrying capacity of the blood by stimulating the 
production of red blood cells and transcription is increased in response to hypoxia 
(Haase, 2013). Studies of the EPO gene identified the hypoxia response element 
(HRE) flanking the 3’ enhancer region (Shah and Xie, 2014). Subsequently the 
protein Hypoxia Inducible Factor-1 (HIF-1) that binds to HRE under hypoxic 
conditions was identified (Semenza, 2004). HIF-1 is a transcription factor which is 
constitutively expressed but rapidly degraded by the ubiquitin-proteasome system in 
the presence of oxygen. In the kidney, activation of HIF-1 provides protection from 
ischaemia-reperfusion and radiocontrast-induced injury (Semenza et al., 1997; 
Heyman et al., 2008). Semenza and his colleagues demonstrated that the increased 
expression of HIF-1α protects kidney from both morphological and functional injury 
during ischaemic preconditioning (Semenza, 2003).  
1.3.1.1.1 HIF-1α and its activation 
HIF-1 is a basic helix-loop-helix-Per-ARNT-Sim (bHLH-PAS) protein consisting of two 
key subunits alpha and beta. HIF-α has 3 isoforms, HIF-1α, HIF-2α and HIF-3α (Wu 
et al., 2015). HIF-2α shares 48% amino acid sequence identity and structural and 
functional similarities to HIF-1α. In contrast to HIF-1α expression which is primarily 
expressed in the tubules, HIF-2α is expressed in endothelial and interstitial cells of 
the hypoxic kidney  (Ke and Costa, 2006). HIF-1β is aryl hydro-carbon nuclear 
translocator and is constitutively expressed in all cells. Unlike HIF-1β, HIF-1α has a 
short half-life of 5 minutes (Ke and Costa, 2006). The presence of oxygen-dependent 
degradation domain facilitates oxygen-regulated stability (Ziello et al., 2007). In 
normoxic conditions, HIF-1α is continuously synthesised and degraded (Gunaratnam 
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and Bonventre, 2009). The proline residues (P-402 and P-564) and asparagine (N-
803) are hydroxylated by prolyl hydroxylase domain (PHD) and by factor inhibiting 
HIF-1 (FIH-1) (Bruick and McKnight, 2001). Furthermore, acetylation of lysine residue 
(K-532) by arrest defective-1 (ARD1) promotes HIF-1α interaction with the von 
Hippel-Lindau protein. This leads to ubiquitination HIF-1α forming E3 ubiquitin ligase 
VHL complex leading to proteasomal degradation (Jaakkola et al., 2001).   
During ischaemia, HIF-1α is stabilised. The hydroxylation of proline and lysine along 
with acetylation of asparagine mediated by PHD, FIH-1 and ARD1 is blocked due to 
lack of oxygen. HIF-1α interacts with CBP/p300 and translocates to nucleus where it 
dimerizes with HIF-1β and becomes transcriptionally active (Semenza, 2000; 
Semenza, 2001).  
1.3.1.1.2 Downstream effects of HIF-1 signalling 
Several biological processes that are essential for kidney function under 
physiological and pathological conditions are regulated by HIF-1. Although the 
number of genes directly and indirectly regulated by HIF-1 has grown rapidly, it is still 
not clear which signalling pathways mediate this protective effect.  During hypoxia, 
HIF-1 exhibits cytoprotective effect by regulating anaerobic glycolysis, protein 
translation, cellular proliferation, and apoptosis (Higgins et al., 2007).  An increased 
HIF-1α expression was observed in kidneys of rats exposed to various hypoxic 
stimuli (Rosenberger et al., 2002). Another study showed that knockdown of HIF-1α 
in mice inhibits fibrosis progression by reducing inflammation and ECM deposition 
post UUO (Higgins et al., 2007).  Moreover, HIF-1α heterozygous mice were more 
susceptible to renal IRI and suffered substantially more injury post IRI when 
compared with controls thus proposing a protective role of HIF in IRI to the kidneys 
(Kojima et al., 2007).  
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Furthermore, HIF-1 promotes cell proliferation/survival in certain cells types by 
stimulating the production of several cytokines and growth factors such as insulin-like 
growth factor-2 (IGF2) and TGF-β (McClintock et al., 2002). Several clinical findings 
suggest that HIF-1 could potentially lead to a path of renal fibrosis by direct 
regulation of fibrotic factors and by acting synergistically with TGF-β. Studies suggest 
that hypoxia promotes fibrosis by increasing SMAD3 mRNA levels and by activating 
TGF-β signalling via thrombospondin-dependent release of latent TGF- β (Sánchez-
Elsner et al., 2004; Heikkinen et al., 2010).  
Studies have shown that hypoxia leads to HIF-1 dependent dedifferentiation and 
transition of renal epithelial to mesenchymal fibroblast-like cells characterised by loss 
of E-cadherin at intracellular junctions, increase in motility and reorganisation of the 
actin cytoskeleton (Higgins et al., 2007). Paradoxically, adaptation of a cell to hypoxia 
assures prolonged proliferation/survival in some circumstances and cell death in 
other circumstances. Genetic studies using embryonic stem cells have demonstrated 
that the expression of HIF-1 is significantly correlated with apoptosis since it 
mediates activation of caspase-3 and Apaf-1-mediated caspase-9, and the release of 
cytochrome under hypoxic conditions (McClintock et al., 2002). 
1.3.2 Reperfusion 
Post ischaemia, reperfusion restores the flow of oxygenated blood causing an 
increase in oxygen levels. This normalisation is associated with damage to tissues. 
An increase in mitochondrial calcium content, production of ROS and a reduction in 
antioxidant capacity lead to structural cell injury and cell death. Overall these 
processes  are termed Ischaemia Reperfusion Injury (IRI) (Devarajan, 2005; 
Devarajan, 2006). Experimental finding suggest that in an event of ischaemia-
reperfusion injury, ischaemia accounts for 17% cell death while 73% cell death 
occurs post ischaemia-reperfusion injury (Padanilam, 2003) (Figure 1.3). 
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1.3.2.1 Oxidative stress  
During the reperfusion phase of IRI, xanthine oxidase catalyses conversion of 
hypoxanthine to xanthine to yield hydrogen peroxide which forms highly reactive 
hydroxyl radicals in presence of iron. These free radicals cause renal tissue injury via 
peroxidation of membrane lipids and oxidative damage to proteins and DNA which 
contribute to apoptosis and cell death  (Malek and Nematbakhsh, 2015). 
Recent studies have shown the beneficial effects of supplements containing 
antioxidants and free radical scavengers on IRI in animals. The antioxidant activity of 
melatonin prevented free radical-mediated renal damage during the reperfusion 
period post ischaemia (Mune et al., 2002). Furthermore, the antioxidant activity of 
Ulinastatin and Propofol protects kidney from IRI by inhibiting apoptosis, neutrophil 
infiltration, lipid peroxidation and cytokine production. Herbal antioxidants such as 
picroliv, naringin and aqueous garlic extract have shown protective effects on IRI 
(Rakesh et al., 2010).  
1.3.2.2 Mitochondrial dysfunction 
Post ischaemia, the exposure of mitochondria to large amounts of calcium and free 
radicals contributes to progressive functional deterioration (Szeto et al., 2011). 
Increased intracellular calcium overload can trigger several calcium mediated 
pathways that may contribute to cell death (Kosieradzki and Rowiński, 2008). 
Therapeutic agents with antioxidant properties are being developed to reduce 
damage caused to mitochondria post IRI (Cho et al., 2007). 
1.3.2.3 Nitric oxide 
Nitric oxide produced during ischaemia reacts with superoxide to form peroxynitrite 
leading to protein nitrosylation.  The importance of protein nitrosylation in tissue injury 
  
14 
 
is supported by studies using inhibitors of iNOS which result in in reduced lipid 
peroxidation and inflammation (Jeong et al., 2008).  
1.3.3 Cellular and metabolic consequences of tubular injury 
Ischaemia-reperfusion affects cell viability and activates different programs of cell 
death.  Necrosis is a chaotic process characterised by loss of membrane integrity, 
cytoplasmic swelling followed by fragmentation of a cell and its components. Cells 
release molecules that stimulate inflammation and tissue damage (Padanilam, 2003). 
Apoptosis in contrast involves activation of a complex caspase signalling cascade 
leading to cytoplasmic shrinkage, DNA fragmentation and formation of apoptotic 
bodies. Loss of tubular cell leads to loss of tubular re-absorptive and excretory 
function and reduced GFR (Havasi and Borkan, 2011). Animal studies have shown 
that blocking of pro-apoptotic protein Bax and Bid, caspases (1, 6 and 7) protects 
mice from cisplatin induced renal injury by reducing tubular apoptosis, neutrophil 
infiltration, and improved renal function (Faubel et al., 2004; Wei et al., 2007; Yang et 
al., 2008).   
 
Figure 1.3 Pathophysiology of IRI. Alterations in cell metabolism post IRI. Adapted 
from (Cao et al., 2013) 
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1.4 Tissue Repair after IRI 
During maladaptive repair post AKI, there is increased numbers of myofibroblasts 
that contribute to the deposition of fibrotic matrix components such as collagen 
(Ferenbach and Bonventre, 2015). The different components of extracellular matrix 
released during kidney injury are discussed below. 
1.4.1 Extracellular matrix synthesis 
Although kidney can recover form an insult of IRI, there are long term detrimental 
effects of even brief periods of IRI. To undergo repair, cells initiate signalling 
pathways that lead to activation of genes causing production and accumulation of 
extracellular matrix proteins within the interstitial space (Lan, 2003).  
1.4.1.1 Collagen  
Collagen constitutes the main structural element of the interstitial ECM. In 
physiological conditions, collagen I and III are expressed at low levels in the 
glomeruli and the renal interstitium. During fibrosis, collagen I and III accumulates in 
the tubulointerstitial space, glomeruli and arterial walls thus contributing to 
development of CKD (Genovese et al., 2014).  
1.4.1.2 Glycoproteins 
Due to high carbohydrate content, proteoglycans may play an important role in 
growth factor binding. They are found in the renal extracellular interstitial space 
where they act as a reservoir of profibrotic growth factors such as the latent forms of 
TGF-β (Fan et al., 1999). Small leucine rich proteoglycans such as decorin and 
biglycan are highly expressed in the tubulointerstitium and play an important role in 
collagen fibrillogenesis. Animal model studies show biglycan upregulation before 
macrophage infiltration is associated with tubular inflammation (Hsieh et al., 2014) 
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and decorin modulates the activity of TGF-β1 signaling (Cabello-Verrugio and 
Brandan, 2007). 
1.4.1.3 Metalloproteinases (MMPs)  
Metalloproteinases (MMPs) are matrix-degrading enzymes that play a central role in 
maintaining the homeostasis of the ECM, destruction of the basement membrane, 
angiogenesis, cell migration and cell apoptosis (Kugler, 1998; Kunugi et al., 2011).  
An increased expression of MMP-2 and MMP-9 has been reported in animal models 
of renal fibrosis (Caron et al., 2005; Cheng et al., 2006). These may contribute to the 
degradation of basement membrane and ECM components (Catania et al., 2007).  
1.4.2 Growth factors contributing to the extracellular matrix 
deposition 
Besides their activity on ECM components, MMPs are also known to modulate 
tubular cell responses by controling the expression of cytokines, chemokines and 
growth factors that propagate renal injury, facilitate interstitial inflammation and/or 
directly contribute to fibrosis. Growth factors identified in renal tissue act as potent 
mediators in the development of fibrosis. These include epidermal growth factor 
(EGF), TGF-α, TGF-β, platelet derived growth factor (PDGF), fibroblast growth factor 
(FGF) and insulin-like growth factor IGF and Angiotensin II (Liu, 2010).    
TGF-β a key mediator involved in regulating fibrosis and is known to have a direct 
effect on the turnover of the ECM. Low concentrations of TGF-β are found in a 
normal functioning kidney. Abnormal expression of TGF-β has been documented in 
kidney fibrosis. Studies confirm that deposition of fibronectin, laminins, and collagen 
is facilitated by TGF-β1 and long term increase in TGF-β1 is associated with chronic 
rejection following organ transplantation in humans (Böttinger and Bitzer, 2002).   
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1.5 Transforming growth factor 
The TGF-β is a member of the transforming growth factor superfamily that plays a 
fundamental role in cell proliferation and differentiation, in embryological 
development, oncogenesis, and tissue repair (Verrecchia and Mauviel, 2002). The 
TGF-β superfamily comprises of nodal, activins, inhibins, bone morphogenetic 
proteins (BMPs) and growth differentiation factors (GDFs). Increased TGF-β activity 
is associated with pathophysiological processes including tubular epithelial cell 
dedifferentiation and ECM deposition that may eventually leads to deterioration in 
renal function and renal fibrosis. This ubiquitously expressed and multifunctional 
cytokine is secreted by macrophages, mesengial cells, T cells, tubular epithelial cells 
and myofibroblast in renal fibrosis (Horiguchi et al., 2012).   
In addition to TGF-β, a role for BMP-7 has been suggested in CKD (Meng et al., 
2013). Studies have indicated an anti-fibrotic role of BMP-7, largely mediated by 
opposing the pro-fibrotic effect of TGF-β and reducing ECM formation. It therefore 
has a therapeutic potential in decreasing acute and chronic renal injury (Zeisberg, 
2006; Li et al., 2015). 
1.5.1 Latent TGF-β and its activation  
The TGF-β superfamily contains three isoforms of TGF-β termed TGF-β1, TGF-β2, 
and TGF-β3 which display a variety of proliferative, inductive and regulatory functions 
(Sporn and Roberts, 1992) and exhibit both overlapping and distinct patterns of 
expression during development (Pelton et al., 1991), wound healing and in disease 
conditions (Böttinger and Bitzer, 2002). The three isoforms exhibit 71–79% amino 
acid sequence identity and the function of the different isoforms appears to be similar 
in vitro. However, the phenotype of knockout mice is different for each isoform 
suggesting distinct functions of the isoforms in vivo (Annes et al., 2003). 
  
18 
 
The activation of TGF-β is localised to sites where its released from its latent form. 
Each member is synthesised as a large peptide that comprises of N-terminal portion 
called the latency-associated peptide (LAP), a short C-terminal fragment that is the 
mature cytokine and a signal peptide to direct TGF-βs to the endoplasmic reticulum. 
This peptide is subjected to intracellular cleavage by furin to form small latent 
complex (SLC) that although the amino bonds between LAP and the mature TGF-β 
are cleaved they remain noncovalently associated (Janssens et al., 2003). The SLC 
then associates with Latent TGF-β binding protein (LTBP) via interactions with LAP 
forming the large latent complex. LTBP facilitates binding of the large latent complex 
to proteins of the extracellular matrix (Kusakabe et al., 2008).  
1.5.2 Activation of TGF-β 
Latent TGF-β is converted to its active form by changes in pH (2-8), heat (1000c) or 
due to action of ROS, plasmin and TSP-1 (Flaumenhaft et al., 1993).  
Changes in temperature and pH activate latent TGF-β in biological samples in vitro. 
However, it is not clear whether activation of latent TGF-β by any of these conditions 
is physiologically relevant (Gleizes et al., 1997).  
1.5.2.1 Activation by Plasmin 
Plasmin are primarily involved in ECM degradation (Blakytny et al., 2004). Several 
studies have indicated the activation of Latent TGF-β by plasmin by cleavage of LAP 
from the latent complex (Khalil, 1999).  
1.5.2.2 Activation by Thrombospondin-1 
Among the five isoforms of Thrombospondin, Thrombospondin-1 (TSP-1) has been 
most widely studied (Lawler, 2002). TSP-1 is also expressed in a number of tissues 
throughout development and facilitates wound repair in several ways: modulation of 
cell adhesion, promotion of angiogenesis, and reconstruction of the matrix (Midwood 
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et al., 2004). TSP-1 binds to LAP leading to disrution of the complex and release of 
boiactive TGF-β. The in vivo role of TSP-1 as an activator of latent TGFβ was 
suggested when TSP-1 null mice exhibited a similar phenotype as TGFβ null mice 
(Froese, 2013).  
1.5.2.3 Activation by Reactive oxygen species (ROS) 
It is hypothesised that ROS leads to TGF-β activation by altering one or several side 
amino acids such as cysteine or methionine residues in LAP. Oxidation of LAP 
causes instability resulting in either loss of its noncovalent association with  TGF-β or 
a conformational change thus exposing the TGF-βR binding site. In animal models of 
ROS generation, increased TGF-β activation is evident (Hegde et al., 2005).   
1.5.2.4 Activation by pH 
Changing pH causes TGF-β activation by inducing denaturation of the LAP protein, 
which disturbs the interaction between LAP and TGF-β. No activation of human 
derived L-TGF-β was observed at a pH above 3.5. A change in pH below 3.1 and 
above 11.9 led to L-TGF-β activation (Nocera and CHU, 1995).  
1.5.2.5 Activation by Heat  
Heating is considered more effective and efficient in generating active TGF-β than 
acid treatment. Activation of TGF-β occurs more when temperature is around 70-
80°C for 10 minutes while denaturation occurs if temperature rises above 80°C 
(Annes et al., 2003).  
1.5.3 Structure of TGF-β receptors for TGF-β family 
TGF-β transduces its signal by bringing together two transmembrane receptors 
kinases, TGF-βRI and TGF-βRII (Wrana et al., 1992). Ligand induced oligomerization 
of type I and II receptors initiates a transphosphorylation cascade (Greenwald et al., 
1999). This starts with type II receptor phosphorylation of type I receptor leading to 
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the activation of its kinase activity. The activated type I kinase receptors in turn 
activate members of receptor mediated SMAD proteins (R-SMADs) and non-SMAD 
pathways. This model of signalling involving type I and II receptors and the type II 
receptor phosphorylation of type 1 receptor is common amongst all proteins of the 
TGF-β superfamily (Wrana et al., 1994). Furthermore, there are seven human type I 
receptors and 5 type II receptors to which the individual members of the TGF-β family 
bind to in different combinations (Table 1.2).  
 
Table 1.2: List of all ligands, receptors and SMADs involved in the TGF-β 
superfamily. (Akhurst and Hata, 2012) 
For example, the type II activin receptor ActRIIA/B can combine with the type I 
receptor ActRIB/ALK4 and mediate the downstream activin signalling. Another 
example of multiple receptor interaction is BMP type II receptor BMP-RII combing to 
three different type 1 receptors namely BMP-RIA, BMP-RIB and ActRI/ALK2 
(Derynck and Feng, 1997). Upon dimerisation of receptors, the ligands TGF-β, activin 
and nodal induce phosphorylation of SMAD 2 and 3 while BMPs phosphorylate 
SMAD 1, 5 and 8 (Hinck, 2012; Moustakas and Heldin, 2014).  
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1.5.4 TGF-β/SMAD signalling pathway 
There are eight SMADs i.e. SMAD 1-8. SMAD 2 and SMAD 3 are activated via 
phosphorylation of carboxyl terminal by TGFβR-I and ActRIIA whereas SMAD 1, 5 
and 8 are activated by ALK-1, ALK-2, ALK-3/ BMP-RIA and ALK-6/BMP-RIB in 
response to ligand binding (Itoh et al., 2000). These activated SMADs are termed 
receptor-regulated SMADs/ R-SMADs that upon phosphorylation form a complex with 
SMAD 4 before translocating to the nucleus. Studies suggest that SMAD 4 is not 
always required to activate the downstream signalling pathways as even in the 
absence of SMAD 4 some TGF-β responses occur (Sirard et al., 2000; Moustakas et 
al., 2001). The expression of inhibitory SMADs (I-SMADs), SMAD 6 and SMAD 7 is 
regulated by extracellular signals. I-SMADs repress the signalling by competing with 
R-SMADs for their binding to activated type I receptors and preventing 
phosphorylation of R-SMADs. For example, SMAD 7 strongly binds to the activated 
type I receptors for TGF- β /Activin and BMP, inhibits phosphorylation of SMAD 1/5 
or SMAD 2/3 and represses the signalling cascade. SMAD 6 binds strongly to 
activated type I receptors for BMP, and only weakly to TGF-β receptors (Nakao, 
2006). Antagonists of SMADs such as Smurf 1(SMAD ubiquitination- regulatory 
factor 1) and Smurf 2 interact with R-SMADs and target them for ubiquitin–
proteasome-mediated degradation. Smurf 1 interacts with SMAD 1 and SMAD 5 
while Smurf 2 interacts more broadly with different R-SMADs. The former affects 
BMP responses while the latter interferes with BMP and TGF-β/ activin signalling (Lo 
and Massagué, 1999)(Figure 1.4).  
1.5.5 SMAD independent signalling  
TGF-β can also activate other signalling cascades such as MAPK, JNK and ERK 
pathways via SMAD independent pathways. For example, SMAD4 deficient cells with 
additional inhibitor of TGF-β type I receptors could induce MAPK pathway activation 
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in response to TGF-β (Engel et al., 1999). However, the mechanism of MAPK, JNK 
and ERK kinase pathway activation by TGF-β is not well understood. Furthermore, 
activation of MAPK pathways by TGF-β may lead to SMAD phosphorylation allowing 
convergence of TGF- β induced SMAD and MAPK pathways. In this way the balance 
between the direct and indirect activation of SMADs defines cellular responses to 
TGF-β (Yu et al., 2002). 
 
 
Figure 1.4: Overview of TGF-β receptor activation and SMAD signalling.  
(Genome, 2016) 
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1.5.6 TGF-  in kidney diseases 
1.5.6.1 Cell culture models of Renal Fibrosis 
There is growing evidence that tubular epithelial cells (TEC) can phenotypically and 
ultra-structurally become myofibroblasts in response to TGF- in vitro that mimics the 
progression of fibrosis in vivo. Thus, cultured cells including those derived from 
genetically modified animals have been used to study renal fibrosis.  
Cell culture 2D and 3D model have been used to assess total ECM accumulation that 
represents a biological consequence of TGF- activation. Human derived renal 
glomerular epithelial cells, tubular epithelial cells and mouse tubular epithelial cells 
upon stimulation with TGF-1 have shown to undergo morphological changes and 
express matrix proteins (Xu et al., 2007).  Other studies have used rat derived cells 
to study the pathophysiological processes of renal disease, for instance TGF- 
production and ECM production in response to angiotensin II (Kagami et al., 1994; 
Ucero et al., 2013).  
1.5.6.2 Animal and preclinical models 
Animal studies have established the importance of TGF- in renal fibrosis that is 
supported by in vitro studies, demonstrating that TGF- not only induces the 
expression of ECM but also inhibits its degradation by inhibiting matrix 
metalloproteases MMPs and activating the TIMPs (Ma and Chegini, 1999; Hocevar 
and Howe, 2000). In vivo studies have employed the use of nephrotoxins, such as 
cyclosporine, to augment the expression of TGF-1 in renal tubular cells for studying 
interstitial fibrosis. However, the concentrations of cyclosporine administered was 
much higher than its used in clinical practice (Yang et al., 2010a; Kim et al., 2012). 
Furthermore, there are several chemical models for studying renal fibrosis that 
involve administering chemicals into Sprague-Dawley rats (less resistant to 
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developing tissue scarring). Although these agents induced renal fibrosis, the model 
induced liver toxicity. 
The unilateral ureteral obstruction (UUO) model is the most widely used interstitial 
fibrosis model. It shares similar etiology to human obstructive nephropathies and 
reproduces a sequence of events that is similar to that found in human diseases, 
including progressive decline in renal blood flow and glomerular filtration rate, tubular 
epithelial cell damage and a significant increase in renal fibrosis within 1-2 weeks of 
ureteral obstruction (Tan et al., 2007; Grande et al., 2010). Therefore, UUO mouse 
model can be used in research to obtain new therapeutic options for effective 
treatment of renal fibrosis.  
1.5.6.3 Inhibition of TGF- 
Blocking TGF- by using either neutralising antibodies or soluble TBRII alleviates 
renal fibrosis in rat and murine nephropathy models (Liu et al., 1999; Ucero et al., 
2013). However, blockade of SMAD signaling rather than TGF- may provide more 
effective therapeutic strategy for renal fibrosis. It is a clear fact that SMAD7 counter 
regulates TGF/Smad signaling in fibrosis. Several in vitro studies have shown that 
TGF- stimulates SMAD7 expression to exert a negative feedback mechanism in 
renal diseases (Uchida et al., 2000; Schiffer et al., 2001). Overexpression of renal 
SMAD7 by introducing doxycycline-regulated SMAD7 cDNA into the kidney 
significantly inhibited SMAD 2/3 activation and renal fibrosis in a rat UUO model 
(Nakao et al., 1999; Lan et al., 2003).   
The antifibrotic molecule, Pirfenidone attenuates renal fibrosis in the UUO model by 
decreasing the level of TGFβ and subsequent synthesis of collagen in the renal 
tissue. This suggests that pirfenidone may be applied as a treatment of renal fibrosis 
progression (Shimizu et al., 1998). Although anti-TGFβ therapies are associated with 
improved renal fibrosis (McCarty, 2006). They should be used cautiously because 
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TGFβ is also involved in the immune regulation that restricts inflammation during 
renal injury (Gagliardini and Benigni, 2006). Further studies in animal models are 
required to confirm whether TGFβ is beneficial for combatting the progression of 
renal fibrosis, and to assess whether these therapies can be explored in human 
clinical trials. 
1.6 Role of Integrins in kidney injury 
Integrins are large, membrane spanning, type I transmembrane heterodimeric 
glycoprotein receptors that mediate cell-adhesion. The receptor dimer comprises an 
extracellular head region that traverses the plasma membrane and terminates in 
short cytoplasmic domains. These domains initiate the assembly of large signalling 
complexes and thereby bridge between the extracellular space and the intracellular 
cytoskeleton. Integrin mediated adhesion facilitates migration on ECM, formation of 
platelet aggregates, establishment of intracellular junctions and modulate signalling 
cascades that control cell motility, survival, proliferation, and differentiation (Hood 
and Cheresh, 2002; Danen, 2013).  
1.6.1 Integrin structure, expression and function 
Integrins are formed through noncovalent association of an α and β subunit. There 
are 24 different integrins as a result of combinations airing from 18α and 8β known 
subunits with different binding properties and different tissue distribution. The α 
subunit forms the globular head region and participates in ligand binding along with 
the β subunits (Berman and Kozlova, 1999; Springer and Wang, 2004; Xiong et al., 
2007)(Figure 1.5).  
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Figure 1.5: Structure of an Integrin. Integrin comprises of α and β subunit. The α 
subunit forms the globular head region and participates in ligand binding along with 
the β subunit (Hardin and Bertoni, 2015).  
 
Integrins are expressed by different cell types and play a diverse and important role 
in most biological processes. Many integrins bind to components of ECM by a 
common integrin-binding motif, that is expressed by collagen and fibronectin while 
others bind to receptors present on other on leukocytes and endothelial cells 
(Ruoslahti, 1991). Mice models provide much insight into the pattern of distribution 
and functions of specific integrin heterodimers during disease or embryogenesis. 
Blocking the α1 subunit has shown to increase collagen synthesis while blocking of 
α2 results in reduced platelet function with increased vascularisation following 
wounding (Lowell and Mayadas, 2012). Mice lacking α5 have defects in mesoderm 
and vascular development while αv knockout mice exhibit neuro-epithelial and to 
cerebral vascular defects (Astrof and Hynes, 2009). The β6 integrin expression is 
restricted to the epithelia and binds to fibronectin with high specificity  (Breuss et al., 
1995). The β5 integrin is highly expressed in the glomerulus, juxta glomerular 
apparatus, proximal convoluted tubules and collecting tubules and epithelial cells of 
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proximal tubules of the kidney (Pasqualini et al., 1993). This demonstrates that every 
integrin has a specific expression pattern, different functionality and downstream 
effect.  
1.6.2 Role of integrins in TGF-β activation  
In addition to their direct effects on cellular proliferation and survival, integrins interact 
with a variety of growth factor pathways associated with cell proliferation and 
differentiation. In vertebrates, αvβ3 integrin interacts with the transmembrane 
receptors for VEGF, PDGF and IGF while α5β1 integrin interacts with the EGF 
receptor activating growth factor signalling, ECM deposition and promoting fibrosis. 
Several studies indicate there is extensive crosstalk between integrins and TGF- β 
signalling. TGF- β regulates the expression of integrins, their ligands and integrin-
associated proteins therefore influencing integrin-mediated cell adhesion and 
migration. Conversely, several integrins directly control TGF- β activity by interfering 
with SMAD-dependent and SMAD-independent TGF- β signalling in several ways. 
This includes regulating the expression of TGF-β signalling pathway components, 
physical association of integrins with TGF- β receptors and downstream modulation 
of effectors (Danen, 2013). Once the integrin binds latent TGF-β, the activation 
occurs by two proposed mechanisms.  
The first mechanism involves the use of proteases where integrins serves as a 
common docking point for latent TGF-β and proteases. The second mechanism 
involves an interaction between LAP and integrin leading to generation of a 
mechanical force causing a conformational change in the complex that allows TGF-β 
to bind to its receptor (Annes et al., 2003; Camelo et al., 2013).  
1.6.2.1 Integrin expression in kidney 
Integrin αvβ6 is expressed at low levels in normal kidney and regulates the levels of 
free and active TGF-β in tissues by binding to the LAP/TGF-β complex. Its induction 
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is evident in a broad range of renal diseases that is coupled with chronic 
inflammation and fibrosis. Immunohistochemical staining in previous studies has 
demonstrated prominent αvβ6 staining in the epithelial cell lining, dilated and 
damaged tubules in biopsies of patients diagnosed with membranous 
glomerulonephritis, IgA nephropathy and Goodpasture's syndrome (Reiser and 
Sever, 2013).    
The potential regulatory role of αvβ6 in renal fibrosis has been previously 
investigated by using function-blocking αvβ6 antibodies and a mouse model with 
genetic ablation of the β6 subunit. Treatment with αvβ6-blocking antibody attenuated 
accumulation of activated fibroblasts and reduced interstitial collagen matrix 
deposition and similar inhibition of ECM marker expression was observed in mouse 
lacking β6- subunit (Hahm et al., 2007; Henderson and Sheppard, 2013).  In contrast 
to the integrin β6 null mice, mice lacking β8 subunit demonstrate subtle renal 
abnormalities characterised by albuminuria as absence of integrin αvβ8 increases 
levels of bioactive TGF-β leading to glomerular damage (Pozzi and Zent, 2011) 
Integrin α3β1 which is highly expressed in the glomerulus and tubules is involved in 
podocyte stability and glomerular development. Studies suggest that lack or mutation 
in the α3 subunit leads to development of renal abnormalities such as atrophic 
glomeruli and severe proteinuria due to defects in the collecting duct and glomerulus 
(Kreidberg, 2003). Integrin α1β1 and α2β1 expressed throughout the kidney and on 
leukocytes binds to collagen and their expression is upregulated during renal disease 
(Yurchenco, 2011). Blocking α1 subunit has shown to reduce renal scarring by 
inhibiting leukocyte infiltration while chemical antagonism of α2β1 protects mice from 
developing glomerular fibrosis by regulating collagen synthesis and ROS production 
(Cosgrove et al., 2008).   
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1.7 Hypothesis 
IRI was previously thought to be a transient process, with full recovery of function 
and resolution of the histological lesion, ATN.  However, most recent studies suggest 
that post IRI there is not complete resolution of injury but instead IRI initiates a series 
of events that can lead to progressive loss of renal function. The null hypothesis of 
the study was that there is no relationship between TGF- signalling pathway and 
hypoxic or free radical stress in human proximal tubular epithelial cells.  
 
1.8 Specific Aims 
The main aim of the project was to provide data on the link between AKI and CKD 
and cell changes that occur and predispose to the subsequent decline in kidney 
function. 
1. Establish an in vitro model of renal tubular IRI by using renal tubular proximal 
epithelial cell lines. 
2. Assess whether tubular cells develop a pro-fibrotic phenotype after IRI and 
determine whether these changes rely on the synthesis of intermediates such as 
TGF-β. 
3. Determining the role of αvβ6 integrin in IRI 
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Chapter 2: Material and Methods 
2.1 General Practise 
All experimental procedures were conducted in a containment level II laboratory 
according to the University Health and Safety policy. Control of Substances 
Hazardous to Health forms have been reviewed and signed before starting work. All 
laboratory work and procedures were performed in compliance with the Newcastle 
University publications ‘Safe Working with Biological Hazards’, and ‘Safe Working 
with Chemicals in the Laboratory’. Tissue culture was carried out in containment level 
II microbiological safety cabinets that were routinely cleaned with 70% ethanol prior 
to use and periodically cleaned by "mycoplasma off" spray. All cell culturing 
equipment were sprayed with 70% ethanol prior use. 
2.2 Materials 
Reagents, general chemicals and histological stains were purchased from Sigma 
Aldrich. Cell culture reagents were purchased from; Lonza, Invitrogen and Sigma 
Aldrich. General consumables and cell culture consumables were purchased from; 
Gibco Life Sciences, VWR International and Starlab. GoTaq DNA polymerase was 
purchased from Promega. Reverse transcription reagents were purchased from 
Agilent Technologies and SYBR green PCR kit was purchased from Sigma Aldrich.  
2.2.1 DNA Buffers 
10x Tris-Boric acid EDTA  
10.8g of Tris-base, 5.5g of boric acid and 9.3g of EDTA in 1000ml dH2O with pH 
adjusted to 8.3.  
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2.2.2 Western Blot Buffer solutions 
10x Tris-glycine Running Buffer  
30.3g of Tris-base, 144g of glycine and 10g of SDS was dissolved in distilled water to 
a total volume of 500ml. For electrophoresis, this buffer was diluted to 1x with 
distilled water.  
10x Transfer Buffer  
30.3g of Tris-base and 144g of glycine were dissolved in distilled water to a total 
volume of 1000ml. To make 1x of Tris-glycine transfer buffer, 100ml of 10x Tris-
glycine transfer buffer was added to 200ml of Methanol (ANALAR). The volume was 
then adjusted to 1000ml with 700ml distilled water.  
10x TBS  
87.6g of NaCl and 12.1g of Tris-base were dissolved in distilled water to a total 
volume of 850ml. pH was adjusted to 8.0, and the volume adjusted to 1000ml by 
adding distilled water.  
1x TTBS  
To make 1x TTBS solution, 10x TBS was diluted to 1x using distilled water and 
Tween-20 added to a final concentration of 0.1%. 
Blocking Buffer solution 
5g of Bovine Serum Albumin (BSA) was dissolved in 100ml of TTBS, and stored at 
40C. 
2.2.3 Flow Cytometry Buffer solutions 
Washing solution 
2g of BSA was dissolved in 100ml of PBS and stored at 40C. 
2.2.4 Immunofluorescence Buffer solutions 
Blocking Buffer solution 
50μl of Goat serum/rabbit serum was dissolved in 950μl of PBS and stored at 40C. 
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2.2.5 Bacterial Transformation  
LB agar 
Add 35g of LB Broth with agar (Lennox) (Sigma Aldrich) in 1L of water. Autoclave 
before pouring onto petri dish along with 100g/ml Ampicillin (Sigma Aldrich).  
2.2.6 ELISA (Enzyme Linked Immunosorbent Assay)  
Diluent solution 
TGF-β1 ELISA- 1.4% BSA in 100ml PBS  
TGF-β2 ELISA- 1% BSA in 100ml PBS  
Washing Buffer solution 
Add 0.05% Tween 20 to 1L of 1XPBS 
Blocking Buffer solution 
TGF-β1 ELISA- 1-5 % Tween 20 in 100ml PBS  
TGF-β2 ELISA- 1% BSA in 100ml PBS  
Capture Antibody Solution 
TGF-β1 ELISA- 1/120 Dilution in TGF-β1 Diluent   
TGF-β2 ELISA- 1/180 Dilution in TGF-β2 Diluent   
Acidification and Neutralisation reagents 
1 N HCl (100 mL) - To 91.67 mL of deionized water, slowly add 8.33 mL of 12 N HCl.  
1.2 N NaOH/0.5 M HEPES (100 mL) - To 75 mL of deionized water, slowly add 12 
mL of 10 N NaOH. Mix well. Add 11.9 g of HEPES. Mix well. Bring final volume to 
100 mL with deionized water. 
For each new lot of acidification and neutralisation reagents, measure the pH of 
several representative samples after neutralisation to ensure that it is within pH 7.2-
7.6. Adjust the volume and corresponding dilution factor of the neutralisation reagent 
as needed. 
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2.2.7 Collagen co-culture system  
5X DMEM media 
25ml of 10X DMEM (Sigma Aldrich), 2.5ml of 10% FBS and 0.5ml of penicillin (100 
U/ml) and streptomycin (100 μg/ml) was added to 25ml of DPEC water. 
1M NaOH 
It was purchased from Sigma Aldrich and was sterile filtered using .2µM filter. 
2X NaHCO3 Solution 
Since DMEM media contains 3.71g/L of NaHCo3, a 10X stock solution was prepared 
by adding 1.859g of NaHCo3 in 50ml water. A 2X working solution was further 
prepared by adding 2ml of 10X stock in 8ml of DPEC water. 
2.2.8 ALK5 reconstitution 
10mM stock was prepared by dissolving 5mg of ALK5 Inhibitor- SB505124 (Sigma 
Aldrich) in 1.49ml of 25mg/ml DMSO solution (Sigma Aldrich) to give a working 
concentration of 10mM. Once dissolved, the aliquots were stored at 2-80C before 
further use. 
2.2.9 CoCl2 preparation  
A 10mM stock solution was prepared by mixing 23.7g of weighed cobalt chloride 
(CoCl2) powder (Sigma Aldrich) in 10ml of complete media to give a working 
concentration of 100µM. The stock was sterile filtered prior to use. The stock was 
further diluted to obtain a working concentration and the stock cannot be used again. 
2.2.10 H2O2 solution  
The molarity of 30% w/w hydrogen peroxide (H2O2) was calculated to 8.82M. Based 
on calculations, a 1mM stock solution was prepared by adding 1.13µl of stock H2O2 
solution in 10ml of complete media. The stock was further diluted to obtain a working 
concentration. The stock is freshly prepared for each experiment. 
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2.3 Cell methodology 
2.3.1 Cell culture 
For routine culture, adherent cell lines were grown in 25 and 75cm2 tissue culture 
flasks or 6, 12 and 24 well plates. The cells were grown in a humidified incubator at 
370C with 5% CO2 and tissue culture was carried out in a Class II containment 
cabinet. They were regularly sub-cultured before attaining 80% confluency, with a 
splitting ratio of 1:3 or 1:4 based on cell density. The cells were washed twice with 
sterile phosphate buffered saline (PBS; Lonza) and were incubated with 1mM of 
trypsin-EDTA (Lonza) containing 0.5g/L trypsin and 0.2g/L EDTA at 370C for 5 
minutes. EDTA is a chelating agent that prevents Ca2+ (a divalent cation) facilitated 
adhesion of cells to the flask while trypsin is an enzyme that degrades proteins 
involved in cell adhesion. Detached cells were diluted with equal volumes of media to 
neutralize trypsin and collected in a 15ml tube. The cells were centrifuged (5min, 
1000xG for HKC8 / 300xG for HK-2 and MRC-5), suspended in tissue culture 
medium, counted by haemocytometer if necessary and seeded into new flasks or 
plates.    
2.3.2 Culture Media 
2.3.2.1 DMEM-HAM F-12 media 
DMEM Ham F-12 media (Lonza) was used to grow HKC8 cell line. Complete media 
was obtained by the addition of 5% FBS, 4 mM L-glutamine, penicillin (100 U/ml) and 
streptomycin (100μg/ml). HKC8 cells stably transfected with SMAD-Luciferase 
reporter gene (Courtesy- Dr Ian Logan) were maintained in complete DMEM HAM 
F12 supplemented with 300µg/ml hygromycin B (Lonza) derived from Streptomyces 
hygroscopicus.   
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2.3.1.2 DMEM media 
This media (Sigma, D5546) was used to support the growth of the HK-2 and MRC-5 
cell line. Cells were grown in this medium after the addition of the supplements; 10% 
FBS, 4 mM L-glutamine, penicillin (100 U/ml) and streptomycin (100 μg/ml). 
2.3.3 Cell lines 
2.3.3.1 Human kidney epithelial cell lines (HKC8 and HK-2) 
HKC8 cell are adherent human cortical kidney tubular epithelial cells immortalised by 
transfecting with Adenovirus- 12 SV40 vector (Racusen et al., 1997). HK-2 cells 
(ATCC CRL-2190) were created  by transfecting with and human papilloma virus 
(HPV 16) E6/E7 genes (Ryan et al., 1994). Since they exhibit morphology and 
activity similar to renal tubular epithelial cells and display renal epithelial makers on 
immunohistochemistry, they have been widely considered in several in vitro studies 
to understand the basis of renal injury and fibrosis (Racusen et al., 1997; Veerasamy 
et al., 2009; Prunotto et al., 2011) . HKC8 cells were cultured in complete DMEM 
Ham F-12 media while HK-2 cells were cultured in complete DMEM media (Figure 
2.1).  
 
Figure 2.1: Morphology of PTECs. 
An image of HKC8 (A) and HK-2 (B) cells acquired at 100X magnification. 
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2.3.3.2 Human lung fibroblast cell line (MRC-5) 
The human lung diploid fibroblast cell line MRC-5 (Medical research council cell 
strain 5) was derived from lung tissue of a 14 week old aborted Caucasian male 
foetus by J.P. Jacobs in September of 1966. These cells were cultured in complete 
DMEM media (Figure 2.2).    
 
Figure 2.2: MRC-5 cells under bright field microscope. 
Inverted microscope analysis of MRC-5 cells grown under normal conditions. Image 
acquired at 100X magnification. 
2.3.4 Cell viability  
The cell viability was assessed using typhan blue exclusion assay. 10 μl of cell 
suspension was mixed with 10μl of 0.4% typhan blue (Sigma Aldrich) and incubated 
for 2 minutes. The mix was loaded onto a Neubauer chamber haemocytometer 
covered with a glass slide. The cells were then counted in the corner 4 chambers 
containing 16 squares using a bright field inverted microscope (100X). The 
percentage viability of viable cells that appear white against dark blue background 
was calculated. 
2.3.5 Cell Storage 
In order to maintain a stock of the cell lines and to retain cells from an early passage, 
cells are cryopreserved in liquid nitrogen. Cells in their log growth phase (80% 
confluency) were trypsinised and spun down at 300G-1000G for 5 minutes. The 
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supernatant was discarded and the cells were resuspended in FBS containing 10% 
DMSO (Sigma Aldrich). 1 ml of this cell suspension was added to the cryovial 
(Corning). Before transferring the cryovials to liquid nitrogen, the cells were frozen 
gradually. The cryovial were transferred to Nalgene Mr. Frosty container containing 
isopropanol and stored at -800C. For long-term storage, cells were transferred to 
liquid nitrogen tank. 
For recovery, the frozen cell stock preserved in liquid nitrogen was thawed at 370C in 
a water bath. The cells were transferred to a 15 ml falcon tube and were 
resuspended in 6ml of complete media and centrifuged for 5 minutes. Following the 
removal of supernatant, the pellet was resuspended in 1 ml of media and transferred 
to T25 or 75 flasks containing complete media. 
2.3.6 Mycoplasma testing 
Mycoplasma infection is one of the major risk factors affecting cells in tissue culture. 
Since mycoplasma is not visible by light microscope, it is difficult to determine the 
presence of this type of infection which alters cell morphology and function. Every 3 
month, a test was performed to confirm the absence of mycoplasma infection in all 
cell cultures using a Luminometric assay. This assay was performed on supernatants 
of cells grown for at least 48 h. The cells were tested using MycoAlert™ mycoplasma 
detection kit (Lonza) in accordance with the manufacturer’s instructions.  
2.3.7 WST-1 cell proliferation assay 
Cell proliferation study was assessed using the WST-1 assay (Roche Applied 
Sciences). WST-1 assay utilizes tetrazolium salts to measure metabolic activity in 
active cells. The metabolic activity is largely dependent on the glycolytic production of 
NADPH in viable cells. The nonradioactive, spectrophotometric quantification of cell 
was performed in a 96 well plate. Cells (5x103) were seeded per well in 100μl 
medium. Prior treatment, cells were incubated overnight in serum free media. Post 
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treatment, cells were incubated with 5μl of WST-1 reagent for 120 minutes before 
reading at 450nm by micro-plate reader (ThermoFisher Scientific). 
2.3.8 Establishing co-culture system 
An epithelial-fibroblast co-culture system was prepared, consisting of HKC8 and 
MRC-5 cells. My aim was to develop an in vitro model that best mimics the in vivo 
microenvironment during IRI to study the interaction between epithelial cells and 
fibroblasts. In order to develop a suitable co-culture system, the following 
experimental parameters were optimised. 
2.3.8.1 Collagen concentration  
To calculate the optimum collagen concentration, 1.2 x 105 of HKC8 cells were used 
per well in a 12 well plate. A range of rat tail collagen 1 (Corning) concentration was 
used in order to get a final collagen concentration of 1mg/ml, 2mg/ml, 3mg/ml and 
4mg/ml (Table 2.1). Furthermore, the volume of 1N NaOH was also adjusted to allow 
polymerization of collagen bed within 15 minutes and maintain pH of 7.8 to 8.5. The 
initial optimisation revealed that 2mg/ml of collagen 1 was optimum to allow HKC8 
cells to proliferate (48 h) as a monolayer on the collagen bed and retained the 
collagen bed structure (without contraction). Therefore, for all experiments, 2mg/ml of 
collagen was used. 
 
Table 2.1: Optimising collagen bed concentration. 
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2.3.8.2 Cell seeding density 
Cell seeding density within the collagen was optimised by culturing 1.2 x 105 and 2.5 
x 105 MRC-5 cells in 3mm and 5mm thick collagen beds (2mg/ml). During the 96 h 
growth incubation, media was changed and images were captured to monitor cell 
proliferation.  Thereafter, collagen beds were transferred to petri-dishes washed with 
PBS and digested using 100U/ml collagenase I at 37oC for 2 h on a shaker. The mix 
was then subjected to centrifugation and RNA was isolated from the cell pellet 
acquired. RNA quality and quantity was determined using a Nanodrop and suggested 
that the highest amount of RNA was isolated from 2.5 x 105 MRC-5 cells grown in 
5mm thick collagen bed.  
After optimising the parameters, a 3D co-culture system was prepared that involved 
culturing HKC8 and MRC-5 cells in a single collagen bed. To prepare the bottom 
layer of the bed, 2ml 5x DMEM, 1ml of 2x NaHCO3 and 4.73ml of distilled water was 
added to 2.21ml of rat tail collagen 1(9.02mg/ml). Lastly, 55.25 μl of 1M NaOH was 
added to the mixture. Once the final mix was prepared, it was added to a pellet of 
MRC-5 cells and vortexed. To prepare a 5mm collagen bed, 1ml of mix was loaded 
per well in a 12 well plate and allowed to polymerise for 15 minutes at 37oC. 
Thereafter, 2.5 x 105 HKC8 cells suspended in 1.5ml DMEM media was added to 
each bed and was placed in the incubator overnight. Next day, 1ml of old media was 
replaced by new media and this was done consecutively for 3 days. Following 72 h 
incubation the collagen beds were subjected to quick freezing, H&E staining was 
performed on 5µ vertical sections and visualised under bright field microscope.   
Transwell inserts (Corning) were used to overcome the issue of low cell proliferation 
in the collagen bed. The polyester inserts allow cells to grow as a monolayer and the 
small pore size of 0.4 μM permit diffusion of signalling molecules released by cells. 
To study the paracrine effects of IRI, a system composed of HKC8 cells and MRC-5 
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cells was set-up. HKC8 cells (3x104) were seeded on transwell inserts and MRC-5 
cells (6x104) were grown in a 24 well plate in DMEM complete medium (Figure 2.3). 
Upon reaching confluency, HKC8 cells were stimulated with optimised concentration 
of H2O2 and CoCl2. Post stimulation, HKC8 cells growing on transwell were 
transferred onto naïve MRC-5 cells pretreated with or without ALK-5 inhibitor.  
 
 
Figure 2.3: Schematic presentation of Transwell mesh Inserts (lateral view is 
shown). HKC8 cells were seeded at a density of 3 × 104 cells/well in polyester 
transwell inserts (0.4-μM pore size and a surface area of 0.33 cm2). MRC-5 cells (6 × 
104) were added to the lower compartment. There was no direct cell-contact 
between cell types. HKC8 cells were pre-treated with H2O2 and CoCl2 prior to transfer 
onto wells containing MRC-5 cells. Adapted from Raghnaill et al (Raghnaill et al., 
2014) 
2.3.9 Bacterial transformation 
Bacterial transformation involves introduction of foreign DNA such as plasmid into the 
bacterial cell for either storing or replicating plasmids. These plasmids carry both 
bacterial origin of replication sequence and an antibiotic resistance gene to allow 
selection. Competent E. coli cells stored at -800C were thawed on ice. 10ng of 
plasmid DNA was added to 50l of competent cells and mixed gently by flicking the 
bottom of the tube followed by incubation of ice for 20-30 minutes. The bacteria were 
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subjected to heat shock at 420C in a water bath for 30 seconds and then incubated 
on ice for 2 minutes then 950l of warm LB media was added in each tube. The 
tubes were incubated for 1 h at 370C in shaking incubator (225rpm). 100l of bacteria 
was plated onto agar plates containing antibiotics for selection. The plates were 
incubated overnight at 370C to allow bacteria to grow. 
2.3.9.1 Bacterial culture 
A single bacterial colony was picked and inoculated into a 10ml of LB broth 
containing antibiotic. The cultures were grown overnight on a shaker at 370C. A 
Plasmid mini kit (Qiagen) was used to isolate plasmid DNA from E. coli. Overnight 
bacterial growths were harvested from LB broth by centrifugation at 4000G for 20 
minutes at 40C. The bacterial pellet was re-suspended in 0.3ml of buffer P1, P2 and 
P3. The lysate was centrifuged at 17,900G for 10 minutes. The supernatant was 
collected and was passed though QIAprep 2.0 spin column to allow plasmid binding 
to the silica membrane. The membrane was then washed with buffer PB and PE. 
After washing, the bound plasmid DNA was eluted by adding 50l of water to the 
center of membrane and centrifuged for 1 minute. The quality and quantity of isolated 
plasmid was assessed using Nanodrop 1000 spectrophotometer. 0.8% agarose gel 
electrophoresis was performed to visualise the quality of plasmids (Figure 2.4).  
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Figure 2.4: Plasmid isolation and agarose gel electrophoresis.  
Panel A shows quantity/quality of pHIF-1α plasmid DNA isolated. pHIF-1α, pcDNA3.1 
and pHRE were subjected agarose gel electrophoresis (0.8%) (1µg plasmid, B).   
2.4 Protein expression 
2.4.1 Immunofluorescent cell staining 
Immunofluorescence is a robust and broadly applicable laboratory technique that 
relies on the use of antibodies to identify a specific target antigens by conjugating an 
antibody with a fluorescent dye such as fluorescein isothiocyanate (FITC). These 
labelled antibodies allow localisation and expression levels of proteins of interest to 
be assessed.   
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For immunofluorescence experiments, cells were seeded on glass coverslips in a 6 
well plate with culture medium. The cells were treated once they attain 70-75% 
confluency. Post treatment, the coverslips were rinsed with PBS and fixed with ice-
cold methanol for 5 minutes. After fixing the cells, the coverslips were allowed to dry 
at room temperature and blocked using 1% BSA prepared in PBS at room 
temperature for 1 h to maximize non-specific antibody binding.  
Coverslips were incubated with primary antibody diluted in PBS at 40C overnight 
(Table 2.2). Cells were then washed with PBS 3 times prior to addition of secondary 
antibody (Table 2.3) in PBS at 40C overnight. Following further washing in PBS, the 
nuclei were stained with 1μg/ml DAPI (ThermoFisher Scientific) in PBS for 10mins at 
room temperature. The coverslips were then washed 3 times in PBS and mounted in 
fluorescence mounting medium (DAKO) and sealed with nail lacquer. Image analysis 
was performed with Zeiss Axioimager microscope.   
 
Table 2.2: List of primary antibodies used in IF, WB, FACS and IHC. 
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Table 2.3: List of secondary antibodies used in IF, WB, FACS and IHC. 
2.4.1.1 Quantification of Immunofluorescence per Cell (IF/Cell) 
Images acquired using a Zeiss Axioimager microscope was subjected to 
quantification using Image J software. This software was used to count number of 
nuclei stained with DAPI and calculate the total area of fluorescence (FITC). 
Parameters such as nuclei size to be detected and fluorescence intensity threshold 
were adjusted. The software then counted the number of stained nuclei and total 
fluorescence intensity for each image. Thereafter, total florescence per cell was 
calculated. A total of 9 images per coverslip were analysed and an average of the 
same was plotted. 
2.4.2 Immunohistochemistry (IHC) 
Formalin fixed paraffin embossed 3μm tissue sections were used for IHC analysis. 
Sections were deparaffinised by immersion in 100% xylene for 10min and rehydrated 
though graded ethanol (100%, 95% and 70%) to deionised water.  Endogenous 
peroxidase activity was then blocked using 6% H2O2 in methanol for 15min at room 
temperature and then washed with PBS (pH7.6). This is crucial as antigen is 
detected by peroxidase based methods and the presence of endogenous enzyme 
may lead to nonspecific background staining. For antigen retrieval, the sections were 
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incubated with 20μg/ml Proteinase K solution for 35 minutes at 370C in humidified 
chamber. The proteinase K breaks the protein cross-linking; thereby unmasking the 
antigens in formalin fixed and paraffin embedded tissues. After incubation, the 
sections were allowed to cool at room temperature for 10 minutes and rinsed with 
PBS. To avoid background that may occur when using biotinylated antibodies, 
endogenous avidin and biotin blocking was performed using a streptavidin and biotin 
blocking kit (Vector Labs) for 20 minutes followed by washing for 5 mins.  Sections 
were then blocked for 30 minutes with 20% swine serum and then incubated with 
sheep anti-αvβ6 primary antibody (1:40 dilutions in PBS) for 1 h at room temperature 
and then washed with PBS for 3x5 minutes (Table 2.2). Following this, the sections 
were incubated with biotinylated rabbit anti-sheep antibody (1:200 dilutions in PBS) 
for 2 h at room temperature and then washed with PBS for 5 minutes (Table 2.3). 
The sections were incubated with ABC RTU Elite HP reagent (Vector) for 30 minutes 
at room temperature and were washed twice with PBS each for 3 minutes. During 
this time, 3,3-diaminobenzidine (DAB) was prepared using DAB peroxidase substrate 
kit (Vector) according to manufacturer’s instructions. For staining the extracellular 
matrix, slides were incubated with DAB solution for 7 minutes in the dark conditions. 
For nucleus staining, sections were incubated with Mayer‟s haematoxylin (TCS 
Biosciences) and Scott’s tap water (Leica). Finally, the sections were taken though 
series of dehydration steps (50%, 75%, 95% and 100% ethanol), then into xylene 
before mounting using DPX. Images were acquired using Leica LCM microscope and 
were quantified using NIS-Elements Microscope Imaging Software (Nikon) as per 
manufacturers protocol.  
2.4.3 Flow cytometry 
Flow cytometry is a laser-based technique that can detect characteristics for each 
cell separately while it passes through a laser light source. This technique uses the 
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principle of light scattering or emission of light from fluorochomes and can give 
information on the physical characteristics of the cells. It allows analysis of the 
expression of cell surface or intracellular molecules, estimating the heterogeneity in a 
particular cell population, and defining the purity of an isolated cell preparation.  
The system comprises of a vibrating mechanism that breaks the stream of cells into 
individual droplets. As the flow passes though the measuring station, the reflection or 
refraction of the light according to their size and granularity is measured and detected 
by different detectors and converted into electrical pulses by optical detectors. Light 
scattered in the forward direction of the laser beam is captured by forward angle light 
scatter (FSC) and light scattered perpendicular to the plane of the beam is captured 
by side scatter (SSC). The FSC represents size and shape of the cell while SSC 
gives information about the granularity of the cell.  Based on these two parameters, a 
larger size and more granular cell produces higher forward and side scatter signal.  
Cells can be labelled with different fluorescence dyes that can bind a specific cell 
component or intercalate within DNA or RNA or with fluorochome-conjugated 
antibodies that bind to cell surface receptors and allows detection of specific cell 
surface markers. 
In this study flow cytometry has been used to determine the presence of cell surface 
receptors, using fluorochome-conjugated secondary antibodies that recognise 
primary antibody bound to an antigen of interest. When the fluorochomes are 
stimulated at a particular wavelength, they excite from ground state and emit light of 
lower energy and strong wavelength. After emission, they return to their original 
unexcited state. This emitted light is split into defined wavelengths and channelled by 
a set of filters so that each sensor will detect fluorescence only at a specified 
wavelength.  
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Adherent cells were washed twice with sterile PBS and then scraped using cell 
scrapers. These cells were re-suspended in compete media and centrifuged at 100G 
for 5 minutes. Cells were counted and 2 x 105 cells were used per test. The cells 
were kept on ice throughout the experiment. The cells were washed with 2% FBS in 
PBS before staining with primary or isotype control antibody (Table 2.2). The 
antibody concentration was used as per manufacturer’s recommendation and 
incubated at 40C for 1 h. Then, the cells were washed twice with 2% FBS-PBS 
solution by centrifugation at 500G for 5 minutes. Secondary antibody conjugated to 
fluorochome was added and cells were incubated at 40C for 30 minutes (Table 2.3).  
Finally, the cells were washed twice with FBS-PBS solution at 500G for 5 minutes 
and re-suspended in 200-300 μl FBS-PBS solution. Cells were analysed on a BD 
FACSCanto II flow cytometer and data was analysed using FlowJo software v.7.6.4 
(Treestar). 
2.4.4 Measurement of protein concentration 
2.4.4.1 Enzyme linked immunosorbent assay  
ELISA a plate-based assay technique is specifically designed for detecting and 
quantifying proteins. The specific antigen bound to primary antibody is complexed 
with secondary antibody that is linked to an enzyme. The detection is accomplished 
by measuring the conjugated enzyme activity via incubation with a substrate to 
produce a color based product.   
The quantitative sandwich ELISA technique was performed as per manufacturers 
protocol (R&D Systems Ltd). A monoclonal antibody specific for TGF-β1/β2 was 
diluted to 1:120 and 1:180 in PBS respectively. The wells were coated with 100µl of 
the diluted capture antibody by incubating overnight on a shaker at room 
temperature. The coating medium was discarded and unbound antibody was washed 
using 400µl of wash buffer. Thereafter, 300µl of blocking buffer was added to each 
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well and the plate was incubated for 2 h. After this, blocking buffer was discarded and 
washing was performed. To quantify TGF-β1/β2 production, the cell supernatants 
were collected and centrifuged at 1100G for 4 minutes. To activate latent TGF-β1/β2 
to immunoreactive form, 100µl of cell supernatants were incubated with 20µl 1M 
HCL. Following 10 minutes incubation at room temperature, the acidified samples 
were neutralized by adding 20µl 1.2N NaOH. As per plate plan, 100µl of sample or 
standard were added to the wells and incubated for 2h on a shaker at room 
temperature. After washing away any unbound material, 100µl of detection antibody 
specific for TGF-β1/β2 was loaded into the wells. Following a wash to remove any 
unbound antibody-enzyme, 100µl of substrate solution was added and the plates 
were incubated in dark for 20 minutes at room temperature. The colour development 
was stopped by adding 50µl of stop solution and the intensity of the colour was 
measured by reading absorbance at 492 and 540nm.              
2.4.4.2 BCA protein assay 
Total protein concentration of each sample was assessed calorimetrically using 
Pierce Bicinchoninic Acid (BCA) Protein assay kit (ThermoFisher Scientific) in 
accordance with the manufacturer’s instructions. The assay employs the principle of 
Biurets test in which the reduction of copper ions by protein is detected using BCA 
reagent. The reagent binds to the reduced product to form a coloured product that 
exhibits strong absorbance at 562nm. The intensity of colour is directly proportional 
to the protein content in each sample. In my study, 10μl of serial diluted Bovine 
serum albumin (BSA) standards ranging from 125-2000μg/ml were mixed with 200μl 
of working solution (mixing reagent A with reagent B in a ratio of 50:1) in a 96 well 
plate. The plate was incubated at 370C for 30 minutes prior to reading the 
absorbance at 562nm. A BSA standard curve was generated to evaluate protein 
concentration (Figure 2.5). 
  
49 
 
 
Figure 2.5: Graphical presentation of linear regression model of BSA curve for 
quantification of protein concentration. Cell lysates acquired from HKC8 cells 
were added to wells containing working solution (reagent A: reagent B=50:1). A 
range of diluted BSA (125-2000μg/ml) was added to these wells and the plate was 
allowed to rest for 30 mins at 370C prior to reading the absorbance at 562nm. 
2.4.5 SMAD-Luciferase assay  
2.4.5.1 Block TGF-β signalling using ALK-5 inhibitor 
ALK5 inhibitor- SB505124 (Sigma Aldrich) was used to block TGF-β signalling in 
HKC8 cells. HKC8 cells stably transfected with SMAD-Luciferase reporter gene were 
seeded in 24 well plates. Cells were treated with increasing concentration of ALK5 
inhibitor for 1 h prior to treatment with 10ng/ml TGFβ-1 for 24h. Post incubation, 
media was discarded and SMAD-Luciferase assay was performed to determine the 
optimum concentration that inhibits TGF-β activity significantly (Figure 2.6). Cells 
were lysed with 1X Reporter lysis buffer (4 volume of water to 1 volume of 5X 
Reporter Lysis buffer) (Promega). A single freeze-thaw cycle was performed to aid 
complete cell lysis. The lysates were centrifuged at 12,000G for 5 minutes to pellet 
down cell debris and the supernatant was aliquoted into fresh tubes placed on ice. 
The readings were taken manually using TD20/20 Luminometer (Turner Designs) 
where 30μl of lysate was added to 70μl of Luciferin reagent. The readings were 
further corrected for their protein concentration measured from BCA assay. Another 
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experiment was performed to determine how long a single treatment (1 hr) ALK-5 
inhibitor would have an effect on TGF-β activity. For this reason, cells were 
stimulated with TGF-β1 for 24h. 48h and 72 h post 1h incubation with ALK-5 inhibitor. 
Thereafter, luminescence/ µg of protein samples were measured (Figure 2.7). WST-1 
assay was also performed to assess the effect of ALK5 inhibitor on cell proliferation 
(Figure 2.8). 
 
Figure 2.6: Blocking SMAD-Luciferase activity using ALK5 inhibitor. HKC8 cells 
stably transfected with SMAD-Luciferase reporter gene were treated with varying 
concentration of ALK-5 inhibitor followed by TGF-β1 stimulation (10ng/ml). 
Luminescence/ µg of protein sample was measured and compared to the untreated 
cells. One way ANOVA was used to analyse the data and graphs were plotted using 
Prism 6 software (****=p≤0.0001; n=3). 
 
 
Figure 2.7: TGF-β stimulation for varying time points post ALK5 inhibitor 
treatment. Cells incubated with ALK-5 inhibitor were treated with 10ng/ml TGF-β for 
24 h, 48 h and 72 h. Luminescence/ µg of protein sample was measured. 
Luminescence/ µg of protein in TGF-β treated cells and ALK5 inhibitor and TGF-β 
treated cells were compared to the control. One way ANOVA was used to analyse 
the data and graphs were plotted using Prism 6 software (****=p≤0.0001; n=3). 
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Figure 2.8: WST-1 assay for ALK5 inhibitor treated and untreated cells. Cells 
were treated with 10M ALK5 inhibitor for 48 h and WST-1 assay was performed. 
The controls were untreated cells.    
2.4.5.2 Using αVβ6 integrin blocking peptides 
The αVβ6 integrin-blocking peptide (RTDLDSLRTYTL) and scrambled control 
(TLRDYRDTLSLT) that were originally described by Kraft (Kraft, Diefenbach et al. 
1999) were synthesised by Isca Biochemicals (Exeter, U.K) for this project. Prior to 
use, the lyophilised peptides were reconstituted in sterile PBS according to the 
manufacturer’s instructions to a final concentration of 5µM. The blocking peptide 
were used to determine whether αVβ6 integrin is involved in the regulation of TGF-β 
in IRI. To optimise the concentration of peptide required to block αVβ6 integrin, HKC8 
cells were grown in 24 well plates were exposed to 400µM H2O2 for 4 h. Post- 
treatment, cells were incubated with blocking peptide or the scrambled control in 
complete media (at final concentrations of 50, 100, 500, 1000 and 2500 nM). After 20 
h, the supernatants were collected and transferred onto naïve stably transfected 
SMAD-Luciferase HKC8 cells. Thereafter, luciferase assay was performed to quantify 
active TGF-β1 production, which was optimised using BCA protein assay (Figure 2.8-
1). No changes in luciferase activity was observed when HKC8 cells were incubated 
with scrambled peptide or test peptide. 
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Figure 2.8-1: Effect of αVβ6 integrin blocking peptide on active TGF-β1 
production. Post- treatment with 400µM H2O2 for 4 h, HKC8 cells were incubated 
with varying concentrations of scrambled peptide (negative control) and αVβ6 integrin 
blocking peptide for 20h. Thereafter, supernatants were collected and transferred 
onto naïve stably transfected SMAD-Luciferase HKC8 cells and luciferase activity 
was measured.  
2.4.6 Western Blotting 
Western blotting is used to identify specific protein in a sample of tissue homogenate 
or a mixture of proteins in a cell lysate. Proteins are separated on the basis of size, 
charge or isoelectric points followed by transfer of protein onto a membrane followed 
by identification of the target protein using antibody (Mahmood and Yang, 2012).  
2.4.6.1 Preparation of cell lysate  
Cells were rinsed with PBS and were detached using trypsin-EDTA. The cells were 
pipetted into centrifuge tubes where they were mixed with equal volumes on culture 
media prior to centrifugation for 5 minutes. The resultant pellet of cells was lysed by 
addition of 500μl lysis buffer (Sigma Aldrich) supplemented with protease inhibitor 
(Roche). The lysate was sonicated for 10 seconds followed by cooling on ice for 5 
minutes to avoid protein denaturation due to heat. The sonicated samples were 
centrifuged at 10,000G for 10 minutes at 40C. The supernatants were aliquoted into 
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fresh tubes and the protein concentration was estimated using the BSA standard 
curve (Section 2.4.4.2).   
2.4.6.2 SDS PAGE and Immunoblotting 
15μg of total protein lysate was mixed with 4X Sample loading buffer (Promega) 
containing 5% β-mercaptoethanol. Before loading the sample, the mixture was 
heated at 950C for 5 minutes to cleave disulphide bonds and linearise the proteins. 4-
12% precast polyacrylamide gels (Life Technologies) were used to separate protein 
samples. The gel containing cassette was removed from a sealed pack and was 
gently washed under running tap water to remove traces of unwanted acrylamide. 
The tape at the bottom of the cassette was removed to allow conductance as failing 
to remove will present sample migration. After washing, the cassette was placed in 
an electrophoretic tank, which was filled with 1X running buffer. The comb of the 
cassette was gently removed and the wells were briefly rinsed with running buffer.  
Proteins samples and PageRuler Plus Prestained Protein Ladder (ThermoFisher 
Scientific) were resolved at 180V.  
Before transfer, the nitrocellulose membrane (Hybond, Amersham) was equilibrated 
with absolute methanol for 12 seconds followed by washing with distilled water. The 
gel was removed from the cassette using spatula. A transfer sandwich comprising of 
gel and membrane in the middle followed by transfer buffer soaked paper and foam 
pads on both sides was assembled and enclosed in an electroblotting cassette. The 
cassette was placed in transfer tank containing 1X Transfer buffer. The protein 
samples are transferred onto membrane overnight at 30V. During this process, the 
base of the unit receives constant water flow to avoid overheating. After transfer, the 
blot is washed with 1X TTBS for 5 minutes. To avoid non-specific antibody binding 
blots were blocked using blocking buffer solution for 60 minutes at room temperature. 
Primary antibodies were diluted in blocking buffer solution to optimal concentration 
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(Table 2.2). The membranes were incubated overnight at 40C with continuous 
shaking on a rocker. After incubation, the blots were washed 3 times with 1X TTBS 
for 10 minutes and incubated with HP-conjugated secondary antibody at 40C 
overnight with continuous shaking (Table 2.3). After washing 3 times for 10 minutes 
with 1X TTBS, the blots were developed using Pierce enhanced chemiluminescent 
(ECL) substrate (ThermoFisher Scientific). The oxidation of luminol substrate by HP-
conjugated to secondary antibody allows the detection and visualisation of bound 
antibodies. Depending upon the intensity of signal, the blots were exposed to X-ray 
film (Kodak) between 10 seconds to 5 minutes under dark room conditions.               
The blots were stripped at room temperature for 15 minutes using Restore™ Western 
Blot Stripping Buffer (ThermoFisher Scientific) followed by washing with 1 X TTBS for 
5 minutes and reprobed for GAPDH (loading control) by the same procedure. 
2.5 Molecular biology 
In order to decrease the risk of sample contamination, all reagents and consumables 
used were of molecular biology grade. The reagents used for RNA isolation used 
were RNase free, only sterile filter tips and autoclaved sterile tubes were used during 
the entire process. All pipettes were decontaminated with UV light exposure and the 
RNA isolation area was decontaminated by using RNase removal spray (Sigma 
Aldrich).  
2.5.1 RNA isolation  
RNA was extracted from cells using an ISOLATE II RNA mini kit purchased from 
Bioline according to manufacturer’s instructions. A cell pellet generated by 
centrifugation was lysed by addition of 300μl of cell lysis buffer RLY containing 3.5μl 
of β-mercaptoethanol. The lysate was transferred to an ISOLATE II filter and spun 
down at 11,000G for 1 minute. An equal volume of 70% ethanol prepared in RNase 
free water was added to the filtrate to allow RNA binding to the column and the 
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solution was mixed by repeated pipetting. The resulting suspension was transferred 
to an ISOLATE II mini column and centrifuged at 11000G for 30 seconds. The flow-
though was discarded and the column containing RNA was washed with desalting 
buffer followed by treatment with DNases to digest DNA. The column was washed 
once with buffer RW1 and twice with buffer RW2 and centrifuged between each wash 
as before. Finally, RNA was eluted by addition of 60μl of RNase free water onto the 
silica membrane followed by spin at 10000G for 1 minute.     
2.5.2 Quantification and integrity of RNA in cells  
A Nanodrop spectrophotometer (NanoDrop ND-1000, ThermoFisher Scientific) was 
used to determine the quantity and purity of RNA. Briefly, 1μl of extracted RNA was 
applied on to the platform of the Nanodrop after blanking with 1μl of RNase-free 
water. The machine measures the absorbance at thee wavelengths; 260nm, 230nm 
and 280nm to quantify nucleic acid purity and concentration. The absorption at 
260nm relates to the amount of RNA in samples while absorption at 230 and 280nm 
define the presence of organic chemicals and contaminant proteins in the isolated 
RNA. The purity of the isolated RNA sample was evaluated by examining the ratio of 
absorbance at 260 and 280nm and 260 and 230 nm for each sample. For the 
260/280 rate, a reading in the range of 1.8-2.0 was considered satisfactory. The 
260/230 ratio was used as a second measure of RNA purity with a reading of 2 
considered suitable for cDNA synthesis (Figure 2.9).  
In addition to this, the integrity of isolated RNA was assessed by RNA gel 
electrophoresis. A 1.2% native agarose gel was prepared in 50ml of 1 x TBE buffer 
by gentle boiling in in a microwave for 2 minutes. Once the molten agar solution was 
cooled under running tap water, ethidium bromide (EtBr) was added to give a final 
concentration of 0.5μg/ml. Before loading the sample, RNA sample was mixed with a 
loading dye and was heated to 650C for 5 minutes. When the gel had solidified, it was 
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immersed in electrophoretic unit containing 1x TBE buffer. The sample and ssRNA 
ladder (New England Biolabs) was loaded into the wells. The gel was resolved at 
90V for 40 minutes and the bands for RNA was detected under UV light using an 
Alpha Innotech gel dock and alpha image software (Figure 2.10). 
 
Figure 2.9: Quantification of RNA isolated using NanoDrop ND-1000. RNA 
quality is shown by 260/280 and 260/230 ratios. Ratios between 2.0 and 1.8 are 
consistent with good quality and purity of RNA extracted 
 
Figure 2.10: RNA quality determination.  
The quality of RNA isolated from HKC8 cells was determined by performing agarose 
gel electrophoresis. RNA samples displayed two prominent bands of 28S rRNA and 
18S rRNA. This confirmed that the RNA was intact. 
2.5.3 First strand complementary DNA synthesis  
Before assessing the gene expression of a gene, mRNA has to be reversed 
transcribed to obtain cDNA. This step was performed using Affinity Script cDNA 
synthesis kit purchased from Agilent Technologies. RNase free water was added to 
1pg to 5 μg of mRNA to make final volume to 15.7 μl. To this mixture, 1 μl of 0.5 μg/μl 
28S	rRNA	
18S	rRNA	
HKC8	RNA	
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Oligo dT primer or 3μl of 0.1 μg/μl random primer was added and heated to 650C for 
5 minutes to allow primer annealing. The samples were transferred to ice and a 
master mix was added (Table 2.4). Thereafter the samples were transferred to 
thermal cycler and the conditions were as follows: 450C for 5 minutes, 550C for 1 
hour, 720C for 10 minutes and then cooled to 4 0C.       
 
Table 2.4 cDNA synthesis mix 
2.5.4 Polymerase chain reaction (PCR) 
PCR can be used to measure changes in gene expression by amplifying a specific 
gene from its cDNA template using primers specific to the gene of interest. 
Amplification is achieved by repeated cycles that lead to an exponential increase in 
the amount of PCR product. Every cycle involves 3 steps; 1) denaturation where 
disruption of double stranded cDNA occurs, 2) an annealing step where binding of 
primers to single stranded DNA occurs and 3) an elongation step that allows the 
synthesis of new strand.  
Conventional PCR is a semi-quantitative/qualitative technique where levels of 
amplified product can be visualised by gel electrophoresis. In contrast to this, real 
time PCR (qRT-PCR) forms an amplification plot that has an early exponential stage 
of amplification followed by linear stage where the reaction levels off and finally 
reaching end point plateau stage where the reaction terminates due to exhaustion of 
reagents. The quantity of PCR product is determined in the exponential phase where 
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the amount of product doubles at each cycle and crosses the threshold of detection 
that is called the threshold cycle 
2.5.4.1 Conventional PCR 
Conventional PCR was performed to amplify/identify a gene of interest. The cDNA 
obtained was diluted to 100ng/μl. 13μl of master mix containing 12.5μl of GoTaq 
green mastermix (Promega) and 500nM of each 5’ and 3’ primer (Table 2.5) were 
added to the cDNA. The primers used were reconstituted and diluted to their working 
concentration. To minimise the risk of genomic contamination, exon-spanning 
primers were chosen. The final volume of 25μl was prepared by adding DEPC water. 
The samples were loaded onto thermal cycler. The cycle conditions were as follows – 
950C for 5 minutes, 950C for 1 minute, 55-600C (as per the primer pair) for 1 minute, 
720C for 3 minutes(x35), 720C for 10 minutes and 40C holding temperature. The 
amplified products were resolved on 2% agarose gel (Figure 2.11).  
 
Table 2.5 List of primers used in qRT-PCR 
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Figure 2.11: Identification of housekeeping gene. Amplified product for 18s rRNA 
(A) yielded same size bands for control and treated cells as compared to β actin 
derived amplified products (B). 
2.5.4.2 Quantitative real time PCR  
In this study, SYBR green fluorescent dye was used for quantification of gene 
expression. SYBR green binds to the minor groove of the dsDNA of the PCR product 
and emits a florescent signal at 521nm following excitation at 494nm. The intensity of 
fluorescence increases with each new copy of dsDNA and is detected during the 
extension step of qRT-PCR. A major disadvantage of SYBR Green is that it fails to 
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discriminate the double-stranded DNA from the PCR products and those from the 
primer-dimers, potentially giving a false positive signal. To overcome this, 
dissociation curve analysis was additionally performed to confirm the specificity of 
PCR products.  In this step, the temperature was gradually increased from 650C to 
950C after the PCR run was complete. This leads to breaking of dsDNA to ssDNA 
causing loss of fluorescence as SYBR green only binds to dsDNA (Figure 2.12). 
SYBR Green JumpStart™ Taq ReadyMix™ (Sigma Aldrich) mastermix was used.  
The primers were diluted to 1pmol/μl in nuclease free water. The reaction was 
performed in triplicates in a 20μl reaction mixture containing the following reagents: 
SYBR Green JumpStart™ Taq ReadyMix™ 10μl, Forward and reverse primer mix 
(0.5pmol/μl each) 1μl, Nuclease free water 6μl and cDNA 2μl. The mixture was 
amplified using StepOnePlus Real-Time PCR system (Applied Biosystems) and was 
used to analyse the expression of all genes of interest relative to the housekeeping 
gene. A housekeeping gene is defined as a constitutive gene which is expressed at 
the same level in all cells during both normal and disease states. The reaction 
process was carried out for 40 cycles in the following sequential order: 950C for 2 
minutes to activate Taq polymerase followed by 40 cycles of 950C for 15 seconds 
followed by 1 minute at 55-600C. After completing the 40 cycle run, melt curve 
analysis was performed for all samples.  
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Figure 2.12: SYBR Green principle. SYBR Green is a non-specific dye that binds to 
double stranded DNA. Upon binding, it emits a fluorescent signal of a defined 
wavelength. The excitation and emission wavelength of SYBR Green is 494nm and 
521 nm respectively. 
2.5.4.3 Quantification of gene expression (∆∆CT value) 
The comparative Ct method (∆∆CT) is a mathematical model used to quantify relative 
fold difference between a target gene and control gene. Cycle theshold (CT) is 
defined as number of PCR cycles required for a fluorescent signal to cross a 
theshold that exceeds the background fluorescence. CT values for the target gene 
and CT values for the housekeeping gene are subtracted to calculate the ∆CT value 
for the treated and control group. The ΔCT value for the control group (untreated 
cells) is subtracted from the ΔCT value of the treated group (∆∆CT) which is then 
converted to fold change or relative expression calculated as 2- (ΔCT treated group - ΔCT 
control group).    
2.6 Transfection of epithelial cells 
Cells (3x104 cells /well) were seeded in 24 well plates. Once the cells attained 70-
80% confluency, a transfection reaction was prepared in 1.5ml tubes comprising of 
Opti-MEM media, Lipofectamine LTX and plasmid as per manufacturers guidelines 
(Table 2.6). 
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Table 2.6 Plasmid transfection mix 
The eppendorfs were incubated at room temperature for 5 minutes prior to 
transfection. Following 6 h incubation with transfection mix, cells were incubated with 
complete media for 18 h. To quantify HIF-1α expression in HKC8 cells, luminescence 
was measured to determine whether co-transfecting HKC8 cells with HRE- 
Luciferase (hypoxia response element containing plasmid) and pHIF-1α (plasmid 
containing HIF-1α insert) leads to an increase in luciferase activity due to 
overexpression of HIF-1α (Figure 2.13 & 2.14).  
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Figure 2.13: Plasmid maps of pcDNA 3.1 (A, negative control), HRE-Luciferase 
(B) and HA-HIF1alpha-pcDNA3 (C). Plasmids were purchased from Addgene, USA 
 
 
Figure 2.14: Quantification of HIF-1α expression in HKC8 cells. 
HKC8 cells were transfected with pHIF-1α, HRE-Luciferase and pCDNA 3.1 
(negative control) plasmids. In addition, cells were also co-transfected with HRE-
Luciferase and pHIF-1α plasmid and HRE-Luciferase and pCDNA 3.1 plasmid. Cells 
were then treated with 100 M CoCl2. Luciferase assay was performed and 
luminescence/ µg of protein sample was plotted using Prism 6 software (n=3). 
(****=p≤0.0001) 
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2.6.1 siRNA transfection  
SiRNA transfection involves introducing small interfering RNA (siRNA) or other small 
RNAs into the cells using cationic lipids such as Lipofectamine transfection reagents 
(ThermoFisher Scientific). The positively charged lipid molecules encapsulate the 
siRNA by forming liposomes that facilitate entry into the cell via endocytosis. The 
siRNA enters the cytosol, where it interacts with the mRNA and silences the target 
gene (Chesnoy and Huang, 2000; Hirko et al., 2003). 
Transfection can be categorised as stable and transient transfection. Stable 
transfection leads to long-term incorporation of the nucleic acid that persists in 
subsequent generations. In transiently transfected cells, the DNA/RNA is introduced 
into the nucleus. However, the gene does not integrate into the chromosome. Since 
the outcome is short lived, transiently transfected cells have to be analysed within 96 
h of transfection (Kim and Eberwine, 2010). 
2.6.1.1 Transfection efficiency using fluorescently labelled siRNA 
Human silencer cy3 labelled GAPDH siRNA (Applied Biosystems) was used to 
optimise transfection conditions, where cy3 labelling allowed monitoring the 
localisation of the siRNA. A 20μM stock solution was prepared by resuspending 
lyophilised siRNA in RNase free water. A lipid based transfection reagent, 
Lipofectamine® RNAiMAX Reagent (ThermoFisher Scientific) was used to facilitate 
transfection of siRNA into cells. HKC8 cells (5x103 / well) were seeded in a chamber 
slide (Applied Biosystems) containing 400μl of complete media and allowed to 
adhere to the surface overnight. Thereafter, the complete media was replaced by 
Opti-MEM (Applied Biosystems, Table 2.7). The siRNA stock was diluted to a final 
concentration of 10, 30 and 50nM in Opti-MEM. The siRNA concentration was 
optimised by incubating HKC8 cells with 10nM, 30nM and 50nM control siRNA for 
24, 48 and 72 h while keeping Lipofectamine volume constant (1 µl). After 8 h 
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incubation, the cells were washed with PBS, fixed using ice-cold methanol and 
counterstained with DAPI. The uptake of siRNA was then visualised using 
Axioimager Fluorescence microscope (Zeiss) at DAPI and rhodamine channel 
(Figure 2.15).     
 
Table 2.7 siRNA Transfection reagent preparation (using 1µM stock) 
 
 
Figure 2.15 Optimising transfection control concentration using Cy3 labelled 
GAPDH control siRNA. HKC8 cells were seeded on a 8 well chamber slide and 
transfected with 10nM, 30nM and 50nM cy3 labelled GAPDH control siRNA for 24, 
48 and 72 h using 1 µl transfection reagent for optimising transfection control 
concentration. 
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2.7 Statistics 
Statistical analysis of data was performed using Prism 6.0 (Graph Pad software, San 
Diego USA) software. For evaluating any statistical significance between two groups 
(control versus treated) unpaired t-test was performed. One way Anova with 
Bonferroni correction was used to compare more than two groups (Control versus 
treatment 1/treatment 2). A p value less than or equal to 0.05 was regarded as 
statistically significant and the error bars showed the standard error of mean for each 
sample. Further it was assumed that the same data for each experiment was 
normally distributed. 
The Western blots shown are the best images obtained and not necessarily 
representative of all the data. 
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Chapter 3: Ischaemia and reperfusion injury induces a 
profibrotic phenotype in proximal tubular epithelial cells 
and lung fibroblast cells 
3.1 Introduction  
IRI is one of the major inducers of AKI and is associated with increased morbidity 
and mortality. It involves a series of complex events involving tissue and organ injury, 
in part, though alterations in tissue blood flow and the production of reactive oxygen 
species. In addition, renal tubular epithelial cells are injured, tissue resident 
leucocytes are activated and endothelial cell functionality is impaired. Upon 
reperfusion there is production of H2O2 derived ROS that further facilitate DNA 
damage and cause considerable tissue injury (Dagher et al., 2003; Just, 2007). The 
epithelial damage is further accelerated due to immune activation. Therefore, IRI 
seeds the early development of potentially irreversible cell damage and tubular injury 
with the proximal tubular epithelial cells being most susceptible (Weight et al., 1996; 
Sutton, 2009; Munshi et al., 2011; Denecke and Tullius, 2014). 
Hypoxia inducible factors such as HIF-1α play an important in the progression of 
renal fibrosis. During ischaemia, HIF-1α expression significantly increases and this in 
turn regulates the downstream expression of several genes related to angiogenesis, 
cell growth and differentiation (Weidemann and Johnson, 2008). Studies have also 
indicated increased deposition of interstitial collagen in response to low oxygen in 
human renal fibroblasts, suggesting that hypoxia-regulating factors increase matrix 
production in renal fibroblasts (Ruthenborg et al., 2014).  
To determine the effects of IRI on proximal tubular cell phenotype, an in vitro model 
of hypoxia and free radical stress was established by subjecting proximal tubular 
cells to H2O2 or CoCl2. 
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3.2 Results 
3.2.1 Establishing an in-vitro model of Ischaemia and reperfusion 
injury 
3.2.1.1 Optimising conditions for H2O2 treatment in HKC8 cells 
To mimic oxidative stress in vitro, cells were treated with H2O2. A pragmatic approach 
was taken to determine the H2O2 concentration that induces maximal oxidative stress 
with minimum impact upon cell viability. Cells were incubated with varying 
concentration (200, 400, 600, 800 & 800 µM) of H2O2 for 4 h. Following this, cells 
were incubated with fresh complete media for upto 20 h. Cell viability was assessed 
using trypan blue dye exclusion assay. 85% or greater viability was chosen an 
arbitrary cut off with lower viability suggesting excessive early cell death. When 
compared to untreated group, ≥85% viability was demonstrated at 200 and 400μM 
concentrations of H2O2. Less than 85% viability was observed at higher 
concentrations of H2O2 compared to untreated control cells (Figure 3.1).  
The long-term effects of 200 and 400μM H2O2 on viability was assessed at various 
time points. Following 200μM H2O2 treatment, HKC8 cells maintained ≥85% viability 
for 72 h when compared to the untreated cells. However, cells stimulated with 400μM 
concentration showed a reduction in cell viability after 48 h incubation as compared 
to the untreated control cells due to increased cell death (Figure 3.2). Images of 
HKC8 cells were captured to visualise the effect of oxidative stress on cell 
morphology Morphological changes were not evident at earlier time points. At 72h 
treatment with 200μM H2O2, cells adopted spindle shaped morphology consistent 
with a more fibroblast-like phenotype. Higher concentration of H2O2 resulted in a 
significant reduction in cell number due to cell death (Figure 3.3).  
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Figure 3.1: Percentage cell viability assessment with increasing H2O2 
treatment. Following 4 h H2O2 treatment, cells were incubated with complete media 
for 20 h. The viability was measured using Trypan blue dye exclusion assay and 
compared to the untreated control. One way ANOVA was used to analyse the data 
and graphs were plotted using Prism 6 software (n=3). (*p≤0.05) (****p≤0.0001)  
 
Figure 3.2: Percentage cell viability post 200μM and 400μM H2O2 treatment. 
HKC8 cells were treated with 200μM (A) and 400μM (B) H2O2 for various time points 
and the percentage viability was assessed using Trypan blue dye exclusion assay 
and compared to the respectively untreated control (n=3; unpaired t-test).  (*p≤0.05) 
(****p≤0.0001) 
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Figure 3.3: Morphological changes in HKC8 cell line following H2O2 treatment.   
Following H2O2 treatment, cells were incubated with complete media for several time 
points. Images were captured at 6 h, 12 h, 24 h, 48 h and 72 h using Leica bright 
field microscope (100X). 
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3.2.1.2 ROS generation during H2O2 treatment of HKC8 cells 
To assess whether treatment of HKC8 cells with H2O2 resulted in free radical 
production as predicted, I used a fluorescent probe,  CM2-H2DCFDA (ROS Indicator) 
which is oxidised by free radicals in cells to yield a  fluorescent adduct. Cells were 
incubated with varying concentration (200, 400, 600 & 800 µM) of H2O2 for 4 h. 
Following this, cells were incubated with fresh complete media for upto 20 h. After 24 
h treatment, the assay was performed as per manufacturer’s protocol. The result 
suggested there was an increase in fluorescence in response to higher H2O2 
concentration up to 400μM followed by a decline at 600-800μM due to increased cell 
death (Figure 3.4).  
Due to decreased cell viability beyond 24h with 400μM treatment as demonstrated in 
Figure 3.1, the long-term effect of H2O2 on ROS generation was studied at 200μM. 
Time course experiments revealed an increase in ROS production in cells post-
treatment with 200μM H2O2 compared to untreated control cells (Figure 3.5). These 
observations suggest that H2O2 successfully mimics oxidative stress by increasing 
ROS production in cells. Treatment with H2O2 can therefore be used to understand 
the effects of ROS on gene and protein expression. 
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Figure 3.4: Median intensity emission of CM2-H2DCFDA probe in HKC8 
following H2O2 treatment. Free radical injury was induced by treating HKC8 cells 
with varying concentration of H2O2 for 4 h followed by incubation in complete media 
for 24 h. Cells were stained with CM-H2DCFDA. Fluorescence was measured using 
FACS Canto II flow cytometer (BD Biosciences). 
 
Figure 3.5: An increase in CM2-H2DCFDA emissions following 200μM H2O2 
treatment. Following 4 h incubation with 200μM H2O2, the cells were incubated in 
normal media for 24, 48 and 72 h before staining with CM-H2DCFDA. Fluorescence 
was measured using FACS Canto II flow cytometer (BD Sciences; n=1) 
3.2.1.3 The effect of Ischaemia on HKC8 cells   
Ischaemia was induced in HKC8 cells initially using a hypoxic incubator. The 
percentage viability was assessed after exposing HKC8 cells to 1% oxygen. The 
results indicate equivalent viability for hypoxic cells when compared to control cells 
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(Figure 3.6A). Cells were imaged at 24, 48, 72 and 96 h post hypoxic incubation. 
Cells acquired an elongated phenotype by 72 h (Figure 3.6B) suggesting that 
hypoxia induces cytoskeletal re-organisation.  
MTT assay was performed to evaluate whether hypoxia has an effect on cell 
proliferation. The results indicated significantly reduced cell proliferation in hypoxia 
treated cells as compared to their respective control after 48 h incubation in hypoxic 
conditions (p≤0.0001)(Figure 3.7). 
 
Figure 3.6: Cell viability following hypoxic stress (1% oxygen). HKC8 cells were 
incubated in a hypoxic chamber for time points up to 96 h and cell viability was 
evaluated by Trypan blue dye exclusion assay (n=3; Mean +/- SD). Images were 
captured at 72 h Leica bright field microscope (100X). 
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Figure 3.7: Reduced cell proliferation in HKC8 cells during hypoxia incubation.  
Following growth in control or hypoxic conditions a MTT assay was performed to 
evaluate cell number after 48, 72 and 96 h. Readings were acquired using Multiskan 
FC microplate photometer and compared with baseline/control cells at the same time 
point.(n=2; Mean +/- SD)(****p≤0.0001, unpaired t test)  
During normoxia, the α-subunits of HIF transcription factors (including HIF-1α and 
HIF-2α) are hydroxylated and degraded by binding to tumour suppressor pVHL. In 
hypoxic conditions, proline hydroxylation is blocked leading to HIF-1α stabilisation. 
Studies have shown that cobalt mimics hypoxia by inhibiting pVHL binding to HIF-α 
and causing accumulation HIF-1α and HIF-2α (Yuan et al., 2003; Chachami et al., 
2004). 
Therefore, cells were treated with CoCl2 to induce ischemic changes mediated by 
HIF-1α. To optimise CoCl2 concentration, cells were seeded onto a 6 well plate and 
treated with variable concentrations of CoCl2 (25, 50, 75 and 100μM) in 2 ml media 
for various time points. Following incubation, the cell viability was assessed. 
Changes in percentage cell viability were observed post treatment with 75 and 
100μM of CoCl2 at 96 h only (Figure 3.8). However, change in cell morphology was 
noted at 72 and 96 h incubation from a typical cobblestone epithelial type to a spindle 
cell (Figure 3.9).  
To study the effect of CoCl2 on cell proliferation, a MTT assay was performed. This 
suggests that CoCl2 can lead to an increase in HKC8 cell number upto 48h 
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(**=p≤0.01) and arrested growth at 72 h. Based on results, I hypothesise that HIF-1α 
activation by CoCl2 may lead to an increase in cell proliferation upto 48h followed by 
toxicity of CoCl2 at 96h (Figure 3.10 A). 
An alternative technique was also used to assess cell number. HKC8 cells were 
grown on glass coverslips in a 6 well plate. Cells were incubated with 25, 50, 75 and 
100 µM CoCl2 containing media for 24, 48, 72 and 96 h. Following incubation, the 
coverslips were fixed and the cell nuclei were stained with DAPI. Images were taken 
and the number of stained cells per field were counted using Velocity cell imaging 
software. A significant reduction in cell number was observed as early as 24 h 
following 75 and 100μM of CoCl2 treatment (p≤0.0001) (Figure 3.10B).  
 
Figure 3.8: HKC8 cells maintain viability post CoCl2 treatment.  
HKC8 cells were incubated with various concentrations of CoCl2 upto 96 h and cell 
viability was assessed Trypan blue dye exclusion assay and compared to the 
untreated control cells (n=3; Mean +/- SD). One-way ANOVA with Bonferroni method 
was used for analysis. (*=p≤0.05) (****=p≤0.0001)  
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Figure 3.9: Altered cell morphology following CoCl2 treatment. Images were 
captured at 24, 48, 72 and 96 h post 75 and 100 μM CoCl2 treatment using a bright 
field microscope (X100). 
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Figure 3.10: Cell proliferation assay post CoCl2 incubation. Following growth in 
CoCl2 containing media, MTT assay was performed to assess cell proliferation at 24, 
48, 72 and 96 h. MTT assay indicated an increase in cell number upto 48h in CoCl2 
treated cells followed by a decline at 96 h compared to their respective control 
untreated cells (n=3; Mean +/- SD) (**=p≤0.01, One-way Anova) (A). The alternative 
technique employed staining of nuclei to count HKC8 cells post treatment with 25, 
50, 75 and 100 µM CoCl2 containing media at various time points (n=3; Mean +/- SD) 
( ****=p≤0.0001, One-way Anova)(B). 
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HIF-1α level in response to CoCl2 was assessed by immunofluorescence. Cells 
treated with CoCl2 displayed an increased expression and nuclear localisation of HIF-
1α in CoCl2 stimulated cells compared to control cells (Figure 3.11). Similar 
expression was observed in cells following 96 h stimulation with CoCl2 (data not 
shown). 
 
Figure 3.11: Increased nucleolar localisation of HIF-1α in HKC8 cells following 
treatment with CoCl2. Immunofluorescence (n=3; Mean +/- SD, Unpaired t test) 
shows increased HIF-1α expression in cells stimulated with CoCl2 at 72 h compared 
to the untreated control (****=p≤0.0001). Images were taken at 400X magnification 
using Leica AF imaging unit. The images were analysed using Image J and are 
represented as bar graphs of fluorescence per cell.   
3.2.1.4 Optimising conditions for H2O2 treatment in HK2 cells 
Experiments were also performed in a second cell line to ensure that my findings 
were reproducible. HK2 cells were treated with various concentrations of H2O2 for 4 h 
followed by incubation with complete media for upto 20 h. HK2 cells maintained 85% 
viability at 50 and 100μM H2O2 concentration when compared to untreated control. 
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Increased cell death was observed with H2O2 concentrations above this level 
(p≤0.01; p≤0.0001) (Figure 3.12 A).  
The cells were photographed upto 72 h to monitor morphological changes in 
phenotype (data not shown). As with HKC8 cells, treated HK2 cells demonstrated a 
change in epithelial phenotype when compared to untreated cell (Figure 3.12 B).   
 
Figure 3.12:  Percentage HK2 cell viability following H2O2 treatment.  
HK2 cells were treated with various concentration of H2O2 for 4 h followed by 20 h 
incubation with complete media. The cell viability was subsequently evaluated by 
Trypan blue dye exclusion assay and compared to the untreated control cells (n=3; 
Mean +/- SD) (3.12 A). Images were captured at 72 h using Zeiss Axioimager 
microscope (100X)(3.12 B). (**=p≤0.01, ****=p≤0.0001; One-way Anova) 
3.2.1.5 The effect of CoCl2 on HK2 cells   
The effect of CoCl2 on HK2 cell viability was also assessed. Once confluent, HK2 
cells were subjected to treatment 25, 50, 75, 100, 200 µM of CoCl2 upto 72 h. HK2 
cells were viable for all concentrations of CoCl2 at 72 h (Figure 3.13 A). However, 
HK2 cells appeared spindle shaped and elongated following 72 h incubation with 
100μM of CoCl2 (Figure 3.13 B). 
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Figure 3.13: Viability of HK2 cells following 72 h CoCl2 treatment.  
HK2 cells were stimulated with varying concentration of CoCl2 for upto 72 h and cell 
viability was measured by Trypan blue dye exclusion assay and compared to the 
untreated control cells (n=3; Mean +/- SD)(3.13 A). Images were captured at 72 h 
using Zeiss Axioimager microscope (100X)(3.13 B). 
3.2.2 Changes in expression of pro-fibrotic markers in H2O2, hypoxia 
and CoCl2 in PTECs and fibroblasts. 
3.2.2.1 α-SMA and E-cadherin expression following H2O2 stimulation of HKC8 
cells 
HKC8 cells were treated with concentrations of H2O2 that induced production of 
oxygen free radicals. To study acute effects of free radical injury, HKC8 cells were 
treated with 400μM H2O2 for 4 h after cells attained 80% confluency followed by 
incubation for 20 h in complete media. Immunofluorescence and Western blot data 
suggests a significant upregulation of α–SMA in treated cells compared to untreated 
control cells (Figure 3.14 A and B).   
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Figure 3.14: α–SMA expression in HKC8 cells 24 h following 400μM H2O2 
treatment. HKC8 cells were incubated with 400μM of H2O2 in complete media for 4 h 
followed by substitution with fresh media for 20 h. Immunofluorescence (A, n=3; 
Mean +/- SD) and Western blot (B, n=2) was performed to study the expression at 
protein level. Compared to control cells, α-SMA was significantly increased 
(****=p≤0.0001) post treatment. Images were taken at 400X magnification for α-SMA 
using Leica AF imaging unit. The images were analysed using Image J and data is 
represented as bar graphs of fluorescence per cell. 
The longer-term effects of free radical injury on epithelial cell phenotype was studied 
by subjecting HKC8 cells to 200μM H2O2 treatment for 4 h followed by incubation with 
complete media for 48 and 72 h. Cells stimulated with H2O2 showed a consistent 
upregulation of α–SMA (Figure 3.15) with clear decrease in E-Cadherin expression at 
(Figure 3.16) 48 h and 72 h. The expression of E-cadherin was low at baseline when 
cells have been grown for 48 h and only increased when cells were over 90% 
confluent (control 72h).  
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Figure 3.15: α–SMA expression HKC8 cells 48 and 72 h after exposure to H2O2.   
Immunofluorescence (A, n=3; Mean +/- SD, Unpaired t test) and Western blot (B, 
n=2) studies suggest a significant increase in α-SMA expression following 200μM 
treatment for 48 and 72 h compared to their respective control (**=p≤0.01, 
****=p≤0.0001). Images were taken at 400X magnification for α-SMA using Leica AF 
imaging unit. The images were analysed using Image J and data is represented 
fluorescence per cell.  
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Figure 3.16: E-cadherin expression following H2O2 treatment.  200μM H2O2 
treatment significantly reduced E-cadherin expression (*=p≤0.05, ****=p≤0.0001) (A). 
Similar trend was observed with Western blot (B, n=2) studies. Unpaired T test was 
used to analyse the data. Images were taken at 400X magnification for E-cadherin 
using Leica AF imaging unit. 
3.2.2.2 α-SMA and E-cadherin expression in HKC8 cells in hypoxic conditions  
Cells were subjected to 1% oxygen and the expression of α-SMA and E-cadherin 
was examined. HKC8 cells were cultured in 6 well plates and grown until they 
reached 80% confluency, incubated in a hypoxic chamber (1% O2) for 72 h. Protein 
studies showed an increased α-SMA expression and reduced E-cadherin expression 
(Figure 3.17) in the treated cells compared to the control cells. A similar pattern was 
observed after 96 h in hypoxic conditions. 
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Figure 3.17: Protein expression following hypoxic incubation. Following hypoxic 
incubation, protein studies using immunofluorescence (A, n=3; Mean +/- SD, 
Unpaired t test) and Western blot (B, n=2) suggested that hypoxia induced a 
significant increase in α-SMA expression (***=p≤0.001) and reduced E-cadherin 
expression (****=p≤0.0001) in treated cells when compred to control. Images were 
taken at 400X magnification for α-SMA and E-cadherin using Leica AF imaging unit. 
The images were quantitatively analysed using Image J and are represented as bar 
graphs of fluorescence per cell.  
3.2.2.3 α-SMA and E-cadherin expression after CoCl2 treatment in HKC8 cells. 
CoCl2 mimics hypoxia by stabilising HIF-1α and prevents its degradation. HKC8 cells 
were treated with 100μM CoCl2 for 72 h. Immunofluorescence and Western blots 
(Figure 3.18) studies showed an increase in α-SMA and decrease in E-Cadherin 
expression at 72 h suggesting a profibrotic phenotype due to HIF-1α stabilisation. 
Similar change was observed at 96 h treatment (data not shown).   
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Figure 3.18: CoCl2 treated HKC8 cells show increased α-SMA and reduced 
expression of E-Cadherin. HKC8 cells were treated with 100μM CoCl2 72 h. The 
expression of E-cadherin and α-SMA was assessed using immunofluorescence (A 
and B, n=3; Mean +/- SD, Unpaired t test) and Western blots (C, n=2). Compred to 
control, CoCl2 induced an increase in expression of α-SMA (****=p≤0.0001) and a 
decrease in E-Cadherin expression in treated cells (****=p≤0.0001). Images were 
taken at 400X magnification for α-SMA and E-cadherin using Leica AF imaging unit. 
The images were quantitatively analysed using Image J and are represented as bar 
graphs of fluorescence per cell.  
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3.2.2.4 Overexpression of HIF-1α induces a fibrotic phenotype in HKC8 cells 
To determine whether overexpression of HIF-1α can shift epithelial phenotype to 
more fibrotic one, cells were transfected with pHIF-1α and control pCDNA 3.1 
followed by incubation in complete media for 72 h. The protein expression of E-
cadherin, α–SMA and HIF-1α were investigated. Compared to transfection control, 
overexpression of HIF-1α increased α–SMA and reduced E-cadherin expression 
(Figure 3.19). These observations suggest a clear shift in protein expression - from a 
largely epithelial pattern, to an intermediate or fibrotic pattern.     
 
Figure 3.19: HIF1-α overexpression reduced E-cadherin and increased α-SMA 
expression. Immunofluorescence (A) and Western blot (B) demonstrates reduced E-
cadherin and increased α–SMA and HIF-1α expression post transfection with pHIF-
1α compared to control (untransfected and pcDNA3.1 vector transfected). Images 
were taken at 400X magnification for α-SMA, HIF-1α and E-cadherin using Leica AF 
imaging unit.  
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3.2.2.5 Protein expression in HK2 cells treated with H2O2 and CoCl2  
Experiments performed in HKC8 cells were replicated in a second human proximal 
tubular epithelial cell, HK2. Cells were treated with 100μM H2O2 for 72 h and the 
expression of ECM markers was analysed using Western blot and 
immunofluorescence. A significant increase in α-SMA expression (p≤0.0001) along 
with reduced E-cadherin expression (p≤0.0001) was seen in H2O2 treated cells 
(Figure 3.20). HK2 cells were treated with 100μM CoCl2 treatment for 72 h. 
Immunofluorescence results suggested a significant increase in α-SMA (p≤0.0001) 
and a significant decrease in E-cadherin (p≤0.0001) in treated cells compared to 
controls. Western blotting confirmed these changes (Figure 3.21). These results 
further support the role of HIF-1α in modulating fibrotic phenotype in renal proximal 
tubular epithelial cells.  
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Figure 3.20: H2O2 induces fibrotic phenotype characteristics in HK2 cells.  
HK2 cells were treated with 100μM H2O2 for 4 h followed by incubation with complete 
media for 72 h. Protein expression of α-SMA and E-cadherin was analysed by 
immunofluorescence (A, n=3; Mean +/- SD) and Western blots (B, n=2). Cells 
stimulated with H2O2 show reduced E-cadherin expression (****=p≤0.0001) with an 
increased α-SMA expression compared to the controls (****=p≤0.0001). Western 
blotting data suggested a similar expression pattern. Images were taken at 400X 
magnification for α-SMA and E-cadherin using Leica AF imaging unit. The images 
were quantitatively analysed using Image J and are represented as bar graphs of 
fluorescence per cell. 
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Figure 3.21: CoCl2 treated HK2 cells showed reduced E-cadherin and increased 
α-SMA expression. HKC8 cells were stimulated with 100 μM CoCl2 for 72 h. Protein 
studies using Immunofluorescence data (A, n=3; Mean +/- SD, Unpaired t test) and 
Western Blots (B, n=2) suggest an increased α-SMA expression (****=p≤0.0001) with 
reduced E-Cadherin (****=p≤0.0001) expression post stimulation with CoCl2 
compared with control. Images were taken at 400X magnification for α-SMA and E-
cadherin using Leica AF imaging unit. The images were quantitatively analysed using 
Image J and are represented as bar graphs of fluorescence per cell. 
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3.2.2.6 H2O2 and CoCl2 stimulates myofibroblast generation in MRC-5 cells 
The aim of this work was to establish an in-vitro co-culture system with both fibroblast 
and epithelial cells. The effects of H2O2 and CoCl2 on fibroblast cell line MRC-5 were 
assessed. MRC-5 cells exposed to H2O2 for 4 h followed by 20h incubation in 
complete media and CoCl2 for 24 h show an increased myofibroblast features 
characterised by increased α-SMA expression (p≤0.0001)(Figure 3.22).  
 
 
Figure 3.22: Treatment with 100μM H2O2 and 100μM CoCl2 induces an increased 
α-SMA expression in MRC-5 cells.  
MRC-5 cells were stimulated with 100μM H2O2 and CoCl2. Protein studies performed 
using (A, n=3; Mean +/- SD, Unpaired t test) and Western blots (B, n=2) displays a 
significant increase in α-SMA expression (****=p≤0.0001) compared to untreated 
control. Images were taken at 400X magnification for α-SMA and E-cadherin using 
Leica AF imaging unit. The images were quantitatively analysed using Image J and 
are represented as bar graphs of fluorescence per cell. 
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3.2.3 Gene expression following CoCl2 and H2O2 treatment 
3.2.3.1 Quantitative RT-PCR analysis of fibrotic markers in HKC8 cells  
QRT-PCR was used to evaluate changes in gene expression of fibrotic markers 
following H2O2 and CoCl2 treatment in HKC8 cells. However no significant changes in 
the expression of fibrotic markers were observed. 
3.2.3.2 Changes in fibrotic gene expression at RNA level in HK2 cells 
HK2 cells stimulated with 100μM H2O2 for 4 h followed by incubation in complete 
media upto 72 h displayed a significant increase in expression of the fibrotic markers 
α-SMA (p≤0.01), MMP2 (p≤0.0001), COL1A1 (p≤0.01), TGF-β1 and TGF–β2 
(p≤0.05) when compared to controls. No change in expression was observed in 
TIMP1 expression (Figure 3.23).  A significant increase in MMP2 (p≤0.01) and TGF- 
β2 (p≤0.05, p≤0.01) expression was seen at 72 and 96 h of incubation with 100μM 
CoCl2. TGF-β1 (p≤0.05) and COL1A1 expression (p≤0.0001) was significantly 
upregulated at 96 h incubation (Figure 3.24). These results suggest that H2O2 and 
CoCl2 increase fibrotic gene expression in HK2 cells at RNA and protein level. 
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Figure 3.23: Gene profiling in HK2 cells following H2O2 treatment.  
Expression of α–SMA, TIMP1, MMP2, COL1A1, TGF-β1 and TGF-β2 was analysed 
at 72 h post 100μM H2O2 treatment normalised to 18srRNA and expression levels 
compared to untreated control (N=3). Following 72 h incubation, a significant 
increase in α-SMA, MMP2, COL1A1, TGF-β1 and TGF–β2 expression was 
observed. Unpaired T test was used to analyse the data and graphs were plotted 
using prism 6 software. (*=p≤0.05, **=p≤0.01, ****=p≤0.0001) 
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Figure 3.24: Gene expression in HK2 cells post 100μM CoCl2 treatment. 
The graphs show expression of α–SMA, TIMP1, MMP2, COL1A1, TGF-β1 AND 
TGF-β2 at 72 and 96 h CoCl2 treatment normalized to 18srRNA and expression 
levels compared to untreated control (N=3). A significant fold change in COL1A1, 
MMP2, TIMP1, TGF-β1 and TGF-β2 expression observed. One-way Anova 
Bonferroni method was used to analyse the data and graphs were plotted using 
prism 6 software. (*=p≤0.05, **=p≤0.01) 
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3.2.3.3 Increased expression of fibrotic genes in MRC-5 cells 
MRC-5 cells stimulated with H2O2 and CoCl2 showed a significant increase in 
fibronectin (p≤0.05) and α-SMA (p≤0.001, p≤0.05) expression (Figure 3.25 and 3.26).  
 
Figure 3.25: RT-PCR analysis in MRC-5 cells post H2O2 treatment.  
The graphs show expression of α–SMA and Fibronectin expression at 24 h post 
100μM H2O2 treatment normalised to 18srRNA and expression levels compared to 
untreated control (N=3). A significant increase in α-SMA expression (p≤0.001) was 
observed post H2O2 treatment. Unpaired T test was used to analyse the data and 
graphs were plotted using prism 6 software.  
 
Figure 3.26: RT-PCR analysis in MRC-5 cell post CoCl2 treatment.  
The graphs show expression of α–SMA and Fibronectin expression at 24 h post 
100μM CoCl2 treatment normalized to 18srRNA and expression levels compared to 
untreated control (N=3). A significant increase in fibronectin and α–SMA expression 
(*=p≤0.05) was analysed when compared to untreated control. Unpaired T test was 
used to analyse the data and graphs were plotted using prism 6 software.  
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3.3 Discussion 
Reactive oxygen species, such as H2O2 upon accumulation over extended periods of 
time causes oxidative stress and IRI induce tissue damage. H2O2 is more stable than 
other ROS because it is not itself a free radical (Bae et al., 2015). Studies suggest 
that H2O2 may affect cell-signalling survival pathways and is responsible for the 
modulation of transcription factors involved in cellular response to stress stimuli such 
as hypoxia and oxidative stress (Nakamura et al., 2003). Therefore, in my study, I 
used H2O2 to treat HKC8 and HK2 cells prior to studying the effect of ROS 
generation. Previous studies have used higher concentrations of  H2O2  in human 
proximal tubular epithelial cells (500μM H2O2)(Rhyu et al., 2005) and in an in vitro  
rodent model (1000 μM H2O2)(Armogida et al., 2012). In my study, the optimum 
concentration of H2O2 treatment in HKC8 cells was found out to be 200 and 400μM. 
Whereas for HK2 cells, cells retained >85% cell viability at 100μM concentration. 
Although higher concentrations of H2O2 heightened changes in cell morphology, it 
was also associated with increased cell death. Therefore, further studies were 
conducted using lower concentrations of H2O2 that induced phenotypic changes in 
the cells but kept the cell viability constant.  
Preclinical studies have indicated increased ROS production during progressive 
kidney inflammation and fibrosis, wherein persistent ROS production has been linked 
increased production of fibrotic markers  such as α-SMA and decrease in the 
epithelial marker E-Cadherin (Shen et al., 2016). My study demonstrated similar 
results: H2O2 significant increased the expression of α–SMA and reduced E-Cadherin 
expression in HKC8 cells. For instance, there was 3 fold increase in α–SMA 
expression (Figure 3.15) and 2.5 fold decrease in E-Cadherin expression (Figure 
3.16) in 72 hrs H2O2 (200M) treated HKC8 cells as compared to the untreated 
control. Similar results were seen using HK2 cells. Changes in fibrotic marker 
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expression were also evaluated at RNA level. A significant increase in α-SMA, TGF-
β1 and 2, COL1A1 and MMP2 was observed in HK2 cells. Similar changes in 
expression of α-SMA and type-I collagen post ROS generation has been reported in 
studies of Idiopathic Pulmonary Fibrosis indicating that oxidative-stress promotes 
changes in fibrotic markers (Bocchino et al., 2010). 
Previous studies have used different methods including enzymatic, chemical and 
incubation in an anaerobic chamber to mimic the clinical setting of tissue hypoxia and 
to unravel the underlying mechanisms (Lièvre et al., 2000; Askoxylakis et al., 2011; 
Saxena et al., 2012). However, most models established have drawbacks. They 
either could not induce rapid and/or terminate hypoxia or were not able to exclude 
side effects such as excessive cell death.  To overcome this problem, a hypoxic 
chamber and CoCl2 treatment were used to induce or mimic hypoxia. To mimic 
hypoxic conditions in kidney tubular epithelial cells in vitro, HKC8 cells were 
incubated in hypoxic incubator (1% oxygen) for upto 96 h. There was no significant 
change in cell viability. Previous studies have also indicated that incubating cells with 
1% oxygen has no effect on cell viability and morphology in renal fibroblasts (Norman 
et al., 2000).  
Previous studies have shown that CoCl2 mimics hypoxia via HIF-1α stabilisation in 
vitro in a mouse myoblast cell line (Chen et al., 2017) and rat-derived PTECs 
(Weidemann et al., 2008; Koeners et al., 2014). Therefore, CoCl2 was used as an 
alternative treatment to induce hypoxia. Percentage cell viability was assessed post 
treatment with varying concentrations of CoCl2 at various time points. HKC8 and HK2 
cells treated with 100μM of CoCl2 looked elongated, although this is difficult to 
quantify. The results suggested a shift in the phenotypic characteristics of the cells 
from epithelial to fibrotic as has also been demonstrated in rat derived tubular 
epithelial cells by other researchers (Higgins et al., 2007). Changes have also been 
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reported in renal carcinoma cell lines upon treatment with 50 μM - 200μM CoCl2 
(Zhang et al., 2017). Furthermore, this change in phenotype also correlated with 
increased MMP2 expression at 72 h and TGF-β2 gene expression at 96-h following 
hypoxia incubation at the RNA level. Previous studies have also reported an increase 
in TGF-β2 post 48 h of hypoxic incubation in human endothelial cells (Chu et al., 
2004). Post hypoxic stress there was an increased expression of the fibrotic marker 
α-SMA (10 fold) and reduction in epithelial cell marker E-cadherin (2 fold) in HKC8 
cells (Figure 3.17). Similar trend was observed in HK2 cells. Treatment with CoCl2  
elevated the expression of EMT-related transcription factors such as fibronectin, snail 
and downregulated E-Cadherin in hepatocytes supporting the results observed in my 
study (Kong et al., 2015). Furthermore, these experiments clearly demonstrated 25 
fold increase in HIF1α expression post 100M CoCl2 treatment at the protein level 
compared to untreated control (Figure 3.11). These observations suggest that the 
change in cell phenotype could be induced by HIF1α, rather than other cellular 
effects of hypoxia. 
There are no available human renal fibroblast lines that could be used in this series 
of experiments. The use of a human lung fibroblast line, as a responder line to 
demonstrate potential fibroblast responses, was thought more appropriate that the 
use of a renal fibroblast line from another species to avoid differences in TGF-β 
signalling pathways that may be present in different species. The transcriptome data 
for MRC-5 cells is available and has been compared to other fibroblast cell lines, 
where data suggests that MRC-5 cells show similar clusters (Giannakakis et al., 
2015; Marthandan et al., 2015; Marthandan et al., 2016). Furthermore, MRC-5 cells 
have been extensively used to study the effects of oxidative stress (Sitte et al., 1998; 
Chen et al., 2015; Romeo et al., 2016) and hypoxia (Dai et al., 2003; Mathieu et al., 
2014). Therefore, in my study MRC-5 cells were stimulated with H2O2 or CoCl2 and 
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fibrotic marker expression was examined. Oxidative stress and hypoxia induced two 
fold and four fold increased expression of fibrotic markers in MRC-5 cells respectively 
(Figure 3.22) that has also been previously described in literature (Hamblin and 
Huang, 2013).  Overall the results suggested that H2O2 and CoCl2 induced oxidative 
stress and hypoxia in human renal epithelial cell lines and MRC-5 cells. 
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Chapter 4: Role of transforming growth factor in 
ischaemia and reperfusion injury induced renal fibrosis 
in proximal tubular epithelial cells 
4.1 Introduction 
The previous chapter demonstrates that inducing ischaemic stress by hypoxia and 
CoCl2 and reperfusion stress by H2O2 effectively replicates the in vivo conditions. 
Cells displayed an increased expression of α-SMA and reduced E-cadherin 
expression at protein level. Since TGF-β acts as a central mediator in the 
progression of renal fibrosis (Lan, 2011), further investigation and understanding of 
the effects of TGF-β in response to IRI is required (Gerritsma et al., 1998). SB-
505124 is an activin receptor-like kinase (ALK-5) inhibitor that inhibits downstream 
signal transducers such as Smad 3, Smad 2 of TGF-β signalling. My studies showed 
that SB-505124 reduced expression of α-SMA and maintained the expression of E-
Cadherin in H2O2 or CoCl2 treated HKC8 cells.  
4.2 Results 
4.2.1 TGF-β treatment of PTECs 
Treating cells directly with TGF-β1 offers insight into the role of TGF-β1 in 
progression of renal fibrosis. Experimental findings show that PTECs exposed to 
10ng/ml of recombinant TGF-β1 appear morphologically altered when compared to 
untreated controls (Yu et al., 2003; Xu et al., 2007). I observed that PTECs exposed 
to 10ng/ml of TGF-β1 for 24 h appeared elongated and spindle shaped compared to 
untreated control cells (Figure 4.1). 
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Figure 4.1: Morphological changes in epithelial cells post TGF-β1 treatment. 
HKC8 and HK-2 cells were incubated with 10ng/ml of recombinant TGF-β1 for 24 h. 
Images were acquired at 24 h using a Leica bright field microscope (Magnification 
X100).  
Changes at transcriptional level also assessed after TGF-β1 treatment. QRT-PCR 
was performed on RNA isolated from cultured HKC8 cells subjected to 10ng/ml TGF-
β1 for 24 h. A significant fold increase in α–SMA expression (p≤0.01) with no change 
in TIMP1 expression was seen. TGF-β1 expression was upregulated in stimulated 
HKC8 cells but this change was not statistically significant (Figure 4.2). 
 
Figure 4.2: Gene expression in HKC8 cell line after 24h of TGF-β1 treatment. 
The graphs show analysis of α–SMA, TIMP1 and TGF-β1 expression at 24h post 
10ng/ml TGF-β1 treatment normalised to 18srRNA expression and compared to 
untreated control (N=3). A significant fold increase in α–SMA expression (**=p≤0.01) 
was seen. Unpaired T test was used to analyse the data and graphs were plotted 
using prism 6 software.  
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Due to lack of availability of a suitable human renal fibroblast cell line, a cell line 
derived from human lung fibroblasts were used (MRC-5). MRC5 cells were 
stimulated with 10ng/ml TGF-β1 was studied using conventional and qRT-PCR. Data 
obtained from gel electrophoresis (Figure 4.3 A) suggests an increased expression of 
α–SMA and Fibronectin after 24 h TGF-β1 treatment and qRT-PCR data suggests a 
significant fold increase in α–SMA, Fibronectin, COL1A1 and TGF-β1 (p≤0.01)(Figure 
4.3 B). 
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Figure 4.3: Gene expression in MRC-5 cells following TGF-β1 treatment. 
The expression of fibrotic markers α–SMA and fibronectin was initially examined by 
conventional PCR and 18S rRNA was used as a housekeeping gene (A). The graphs 
(B) show analysis of α–SMA, fibronectin, COL1A1 and TGF-β1 expression at 24h 
following 10ng/ml TGF-β1 treatment using q-RT-PCR. The expression was 
normalised to 18srRNA expression levels and compared to the untreated control 
(N=3). Unpaired T test was used to analyse the data and graphs were plotted using 
prism 6 software. (**=p≤0.01) 
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4.2.2 Expression of pro-fibrotic proteins following TGF-β treatment  
TGF-β1 treatment induced morphological alterations in epithelial cell phenotype 
along with changes in expression of fibrotic markers at mRNA level. The effect TGF-
β1 treatment on protein expression was further examined.  
HKC8 cells were grown until they acquired 70% confluency. This was followed by 
overnight incubation in serum free media. Following this, cells were incubated with 
complete media containing 10ng/ml TGF-β1 for 24 h. Western blot and 
immunofluorescence was performed to examine the expression of fibrotic marker α–
SMA and epithelial marker E-cadherin. Treatment with TGF-β1 increased α–SMA 
(p≤0.0001) expression and reduced E-cadherin (p≤0.0001) expression in PTECs at 
protein level (Figure 4.4, 4.5).   
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Figure 4.4: Protein expression in HKC8 cells following TGF-β1 treatment. HKC8 
cells were treated 10ng/ml TGF-β1 for 24 h. Immunofluorescence data (A, N=3) 
showed a significant increase in α-SMA expression (****=p≤0.0001) and significant 
decrease in E-Cadherin (****=p≤0.0001) in treated cells when compared to control. 
Similarly, Western blots (B, N=2) showed a decrease in E-Cadherin and increase in 
α-SMA expression. Immunofluorescence data was presented as IF/cell, unpaired T 
test was used to analyse the data and graphs were plotted using prism 6 software. 
Images were taken at 400X magnification using a Leica AF imaging unit. 
  
106 
 
Protein expression was also examined in MRC-5 cells. Results obtained from 
Immunofluorescence and western blot data were consistent with gene expression. A 
significant increase in α–SMA (p≤0.05) and COL1A1 expression (p≤0.0001) indicates 
that MRC-5 cells stimulated with TGF-β1 acquire myofibroblast like characteristics 
(Figure 4.6). 
 
Figure 4.5: Protein expression in HK-2 cells following TGF-β1 treatment. 
Immunofluorescence data (A) and Western blot (B, N=2) show an increased 
expression of fibrotic marker along with reduced epithelial marker in HK-2 cells 
stimulated with TGF-β1 for 24 h compared to corresponding control. 
Immunofluorescence images were taken at 400X magnification using Leica AF 
imaging unit. 
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Figure 4.6: Expression of profibrotic markers in MRC-5 cells in response to 
TGF-β1 treatment.  
Following TGF-β1 treatment, Immunofluorescence data (A, N=3) suggest a 
significant increase in α–SMA (*=p≤0.05) and COL1A1 expression (***=p≤0.0001) in 
stimulated cells while Western blot (B, N=2) data shows an increased expression of 
in MRC-5 stimulated with TGF-β1 for 24 h compared to corresponding control. 
Immunofluorescence images were taken at 400X magnification using Leica AF 
imaging unit and bar graphs were plotted (as IF/cell) and analysed (unpaired t test) 
using Prism 6.   
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4.2.3 The role of ALK-5 inhibitor in supressing TGF-β signalling 
4.2.3.1 ALK-5 inhibitor blocks TGF-β mediated profibrotic phenotypic change in 
HKC8 cells 
SB-505124 (Sigma) is a potent inhibitor of TGF-β1 receptor and it inhibits ALK-4, 5 
and 7 mediated activation of SMAD2 and SMAD3. The concentration of SB-505124 
was initially optimized prior to conducting experiments. Results suggested a 
significant increase in TGF-β stimulated cells pre-treated with 0.75µM, 1µM and 
2.5µM ALK-5 inhibitor when luminescence/ µg of protein sample were compared to 
untreated control. However, 10µM ALK-5 inhibitor treatment followed by TGF-β 
stimulation showed a inhibition in luminescence similar to that seen in untreated cells 
suggesting efficient reduction in TGF-β activity (Section 2.5.4.1, Figure 2.6). Next, the 
duration of TGF-β1 stimulation post ALK-5 inhibitor treatment was optimized (Figure 
2.7). Pre-treatment with ALK-5 inhibitor could maintain low TGF-β activity for only 
upto 24h. Therefore, further experiments involved stimulating cells with TGF-β1 for 
only upto 24 h. WST-1 assay demonstrated that ALK5 inhibitor had no effect on the 
cell proliferation upto 48 h of treatment (Figure 2.8). 
HKC8 cells were treated with 10μM SB-505124 for 1 h followed by 24 h TGF- β1 
treatment. Protein studies suggest that TGF-β1 induction of α-SMA and suppression 
of E-cadherin expression was successfully attenuated by SB-505124 pre-treatment 
(S+TGF-β/ALK5; p≤0.001; Figure 4.7).  
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Figure 4.7: Protein expression in TGF-β1 and ALK-5 inhibitor treated HKC8 
cells. HKC8 cells were treated with and without 10μM SB-505124 (S) for 1 h followed 
by treatment with 10ng/ml TGF-β1 for 24 h. Immunofluorescence (A, N=3) and 
Western blot (B, N=2) was performed. One-way ANOVA with Bonferroni method was 
used to analyse the data and graphs were plotted using prism 6 software. Images 
were taken at 400X magnification for α-SMA and E-cadherin using Leica AF imaging 
unit and are represented as bar graphs of fold change in fluorescence per cell. 
(****=p≤0.0001) 
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4.2.3.2 The effect of ALK5 inhibition on ischaemia and reperfusion induced 
changes 
It was shown in the previous chapter that PTEC’s adopt a profibrotic phenotype in 
conditions that mimic IRI. To ascertain whether the observed changes were driven by 
TGF‐β, HKC8 cells were pre-treated by incubation with 10µM of SB-505124 for 1 h 
before treatment with 400μM H2O2 for 4 h and incubation for 20 h. SB-505124 and 
H2O2 treated cells (S+H2O2) retained E-Cadherin expression (Figure 4.8 A) and 
prevented an increase in α-SMA expression when expression was compared to H2O2 
treated cells only (p≤0.0001) (Figure 4.8 B).  
A similar experiment was performed using 200μM CoCl2 treatment for 24 h. Although 
pharmacological inhibition of TGF-β/SMAD signaling preserved epithelial phenotype 
by maintaining E-cadherin expression (Figure 4.9 A) and prevented α-SMA 
expression (Figure 4.9 B), a significant increase in HIF-1α expression was observed 
in SB-505124  and CoCl2 stimulated cells (S+CoCl2) (p≤0.0001) as compared to the 
control (Figure 4.9 C).  This confirms that TGF-β induces the expression of a 
profibrotic phenotype in epithelial cells that may contribute to progression of renal 
fibrosis.  
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Figure 4.8: Protein expression in H2O2 and ALK-5 inhibitor treated HKC8 cells. 
HKC8 cells were treated with and without 10μM SB-505124 (S) for 1 h followed by 
treatment with 400μM H2O2 (4 h + 20 h).  Protein expression of E-cadherin and α-
SMA was analysed using Immunofluorescence (A and B, N=3) and Western blots (C, 
N=2). ALK5 inhibitor prevented the increase in α-SMA expression and maintained 
expression of E-Cadherin in H2O2 treated cells and expression was compared 
untreated cells. One-way ANOVA with Bonferroni method was used to analyse the 
data and graphs were plotted using prism 6 software. Immunofluorescence images 
were taken at 400X magnification using Leica AF imaging unit. (****=p≤0.0001) 
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Figure 4.9: Protein expression in CoCl2 and ALK-5 inhibitor treated HKC8 cells. 
HKC8 cells were treated with and without 10μM SB-505124 (S) for 1 h followed by 
24h treatment with 200μM CoCl2. Immunofluorescence (N=3, A, B and C) and 
Western Blot (N=2, D) were performed. One-way ANOVA with Bonferroni method 
was used to analyse the data and graphs were plotted using prism 6 software. 
Images were taken at 400X magnification using Leica AF imaging unit. 
(****=p≤0.0001) 
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4.2.3.3 ALK-5 inhibitor reduces fibrotic marker expression in a co-culture study 
Several attempts were made to establish a co-culture system with epithelial cells 
growing on the upper surface of the collagen matrix with the fibroblast suspended 
within the matrix. Since MRC-5 cells failed to proliferate in the matrix, an alternative 
approach was designed. 
4.2.3.3.1 Media transfer studies 
An in-vitro co-culture model comprising of HKC8 and MRC-5 cells was established to 
investigate the signalling mechanism leading to progression of fibrosis in in-vivo. In 
this model, HKC8 cells were grown on a 6 well plate. Once confluent, the cells were 
stimulated with 400μM H2O2 for 4h followed by incubation in complete media for 20h. 
Post incubation, the supernatants were collected and transferred to naïve MRC-5 
cells (Figure 4.10). Cells were also culture with 200μM CoCl2 for 24 h the media was 
then replaced by fresh complete media and incubated for 24 h. Media was again 
collected and transferred to wells containing MRC-5 cells. 
 
 
Figure 4.10: Schematic diagram of media transfer study involving MRC-5 cells 
 
Protein data illustrates a significant increase in α-SMA expression in MRC-5 cells 
incubated with pre-conditioned media obtained from with H2O2 (+H2O2) (p≤0.001) or 
CoCl2 (+CoCl2) (p≤0.01) stimulated cells compared to MRC-5 cells incubated with 
control media (Figure 4.11).  
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Also, RT-PCR data suggests a significant fold increase in α-SMA (p≤0.05) and 
Fibronectin (p≤0.01) expression in MRC-5 cells with preconditioned treated cell 
media compared to control (Figure 4.12). 
 
Figure 4.11: Protein expression in MRC-5 cells following media transfer. 
Preconditioned media collected from HKC8 cells treated with H2O2 (4h treatment + 
20 h incubation) or CoCl2 (24h) were transferred onto naïve MRC-5 cells for 24h. 
Immunofluorescence (A, N=3) and Western blot (B, N=2) show that α–SMA 
expression was significantly upregulated in MRC-5 cells incubated with 
preconditioned media obtained from H2O2 or CoCl2 stimulated cells compared to 
unstimulated control (***=p≤0.001)(**=p≤0.01)(A and B). One-way ANOVA with 
Bonferroni method was used to analyse the data and graphs were plotted using 
prism 6 software. Images were taken at 400X magnification using Leica AF imaging 
unit. 
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Figure 4.12: Gene expression in MRC-5 cells following media transfer. Following 
24 h incubation with preconditioned media collected from HKC8 cells stimulated with 
H2O2 or CoCl2, RNA was isolated to study gene expression. A significant increase in 
α–SMA (*=p≤0.05) and Fibronectin (**=p≤0.01) expression was seen in MRC-5 cells 
post 24 h incubation when expression was compared to the control cells. Expression 
was normalised to 18srRNA and expression levels compared to untreated control 
(N=3). One-way ANOVA with Bonferroni method was used to analyse the data and 
graphs were plotted using prism 6 software.  
To identify the molecule responsible for driving the changes in MRC5 cells, cells were 
pre-treated with 10μM SB-505124 for 1 h before 24 h incubation with pre-conditioned 
media. When compared to MRC-5 cells incubated with preconditioned media from 
HKC8 cells stimulated with H2O2 or CoCl2 only, α–SMA expression was significantly 
reduced (*=p≤0.05, **=p≤0.01) in MRC-5 cells pre-treated with 10μM SB-505124 
when expression was compared to MRC5 cells treated with H2O2 or CoCl2 
preconditioned media (Figure 4.13). At mRNA level, MRC-5 cells treated with SB-
505124 and H2O2 or CoCl2 (S+H2O2 and S+CoCl2) demonstrated similar expression 
of α–SMA and fibronectin when compared to control cells which was significantly 
lower than that seen in cells stimulated with preconditioned media without ALK-5 pre-
treatment (+H2O2 and +CoCl2) (Figure 4.14). 
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Figure 4.13: MRC-5 cells pre-treated with ALK-5 showed reduced α-SMA 
expression following media transfer. MRC-5 cells were treated with and without 
SB-505124 (S) for 1 h followed by incubation with preconditioned media for 24 h. The 
expression of α–SMA was examined using immunofluorescence (A, N=3) and 
Western blot (B, N=2) studies were performed. Treatment with SB-505124 
maintained the expression of α–SMA when MRC-5 cells were incubated with 
preconditioned media and expression was compared to cells incubated with 
preconditioned media only. One-way ANOVA with Bonferroni method was used to 
analyse the data and graphs were plotted using prism 6 software. Images were taken 
at 400X magnification for α-SMA using Leica AF imaging unit and are represented as 
bar graphs of fold change in fluorescence per cell. (*=p≤0.05, **=p≤0.01, 
***=p≤0.001) 
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Figure 4.14: ALK5 inhibitor maintained low expression of fibrotic markers in 
H2O2 or CoCl2 treated MRC5 cells 
Analysis of α–SMA and fibronectin expression in MRC-5 cells treated with and 
without SB-505124 followed by incubation with preconditioned media from HKC8 
cells stimulated with H2O2 or CoCl2. Expression was normalised to 18srRNA (N=3). 
Cells treated with SB-505124 and preconditioned media showed a significant 
reduction in α–SMA and fibronectin expression when expression was compared to 
MRC5 cells incubated with preconditioned media only (H2O2 or CoCl2). One-way 
ANOVA with Bonferroni method was used to analyse the data and graphs were 
plotted using prism 6 software. (****=p≤0.0001) 
4.2.3.3.1 Transwell inserts 
I propose that even after the ischaemia and reperfusion insult, cells continue to 
produce growth factors that may drive the progression of injury leading to fibrosis. To 
confirm whether stressed epithelial cells continue to produce active TGF-β even after 
a brief ischaemic or reperfusion insult, HKC8 cells were grown on transwell inserts. 
Once the cells were confluent, they were stimulated with 400μM H2O2 or 200μM 
CoCl2. Post stimulation, the inserts were transferred onto the 6 well plates containing 
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naïve MRC-5 cells. The MRC-5 cells were pre-treated with and without SB-505124 
prior to insert transfer. Following 24 h incubation, the expression of fibrotic markers in 
MRC-5 cells was assessed. This model allowed us to confirm whether the epithelial 
cells continue to produce active TGF-β that will signal to MRC-5 cells. Protein studies 
suggest that treated HKC8 cells induce profibrotic changes in MRC-5 cells which 
were successfully inhibited upon SB-505124 pre-treatment (Figure 4.15).  
A similar trend in fibrotic marker expression was observed at the RNA level. There 
was no change in α-SMA and fibronectin expression in cells treated with SB-505124 
and co-incubated with stimulated HKC8 cells (S+H2O2 or S+CoCl2) and MRC-5 cells 
incubated with untreated HKC8 cells. This showed that SB-505124 treated cells did 
not differ from control cells even in the presence of external stimuli thus confirming 
the role of active TGF-β production in the phenotypic changes observed (Figure 
4.16).  
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Figure 4.15: ALK-5 treated MRC-5 cells co-incubated with HKC8 cells. 
Immunofluorescence (A and B, N=3) and Western blot (C, N=2) demonstrate similar 
α–SMA expression in control and SB-505124 (S) treated MRC-5 cells compared to 
untreated cells incubated with a transwell containing stimulated HKC8 cells. One-way 
ANOVA with Bonferroni method was used to analyse the data and graphs were 
plotted using prism 6 software. Images were taken at 400X magnification for α-SMA 
using Leica AF imaging unit. (****=p≤0.0001) 
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Figure 4.16: Gene expression in MRC-5 cells following mesh transfer. An 
analysis of α–SMA and Fibronectin expression in MRC-5 cells treated with and 
without SB-505124 followed by 24 h incubation with mesh containing HKC8 cells 
stimulated with 400µM H2O2 (4h+20h) or 200µM CoCl2 (24h). Expression was 
normalised to 18srRNA (N=3). MRC-5 cells treated with ALK-5 inhibitor maintained 
similar expression of fibrotic markers at mRNA level. One-way ANOVA with 
Bonferroni method was used to analyse the data and graphs were plotted using 
prism 6 software. (****=p≤0.0001) (***=p≤0.001)(**= p≤0.01) 
4.2.4 SMAD-Luciferase reporter gene studies 
To confirm active TGF-β production by HKC8 cells, a luciferase reporter gene assay 
was used. Stable transfected SMAD-Luciferase HKC8 cells were used in this study 
that show an increased luciferase production in response to active TGF-β.  To 
identify if ischaemia and reperfusion injury induces SMAD signalling, SMAD-
Luciferase cells were grown in a 6 well plate in hygromycin containing media until 
they are 70% confluent. Prior to treatment, cells were incubated overnight in 
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hygromycin free media. The cells were then stimulated with 400μM H2O2 (4h 
treatment + 20h incubation). After 24 h incubation, the cells were lysed and luciferase 
activity was measured. BCA protein assay was performed to calculate luciferase 
activity/μg protein sample. A significant increase in SMAD-luciferase activity was 
seen in cells treated with H2O2 (p≤0.01) compared to unstimulated control (Figure 
4.17).  
 
Figure 4.17: SMAD-Luciferase activity following H2O2 treatment. SMAD-
Luciferase transfected HKC8 cells treated with 400μM H2O2 (4h+20h) show a 
significant (**=p≤0.01) increase in luciferase activity (controlled by a SMAD promoter) 
compared to control cells (N=4). Unpaired T-test was used to analyse the data and 
graphs were plotted using prism 6 software. (**=p≤0.01)   
To further quantify if HKC8 cells produce active TGF-β, media transfer studies were 
performed where supernatants were collected from 200μM CoCl2 stimulated HKC8 
cells or HKC8 cells transiently transfected with HIF1-α plasmid. These supernatants 
were transferred to naïve SMAD-Luciferase cells. Following 24 h incubation with 
preconditioned media, there was increased luciferase activity consistent with 
increased TGF-β production in cells stimulated with CoCl2 or transfected with HIF1-α 
when compared to their respective controls (Figure 4.18). 
HKC8 cells were subjected to 400μM H2O2 (4h treatment + 20h incubation) or 200μM 
CoCl2 (24h) stimulation. Supernatants were transferred onto naïve SMAD-luciferase 
cells treated with and without 10μM SB-505124 inhibitor for 1 h. The increase in 
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luciferase activity on transfer of pre-conditioned media was blocked in cells pre-
treated with SB-505124 (Figure 4.19). 
 
Figure 4.18: SMAD-Luciferase activity post CoCl2 treatment. Supernatants 
collected from 24 h CoCl2 stimulated or HIF-1α transfected cells were transferred 
onto naïve SMAD-Luciferase cells for 24 h. Results showed a significant 
(***=p≤0.001) (****p≤0.0001) increased TGF-β production in CoCl2 stimulated and 
HIF1-α transfected cells compared to untreated cells and transfection control (p3.1) 
respectively (N=4). Unpaired T-test was used to analyse the data and graphs were 
plotted using prism 6 software. (****p≤0.0001)(***=p≤0.001) 
 
Figure 4.19: Effect of ALK5 inhibitor on SMAD-luciferase activity following 
media transfer.  Supernatants collected from HKC8 stimulated with 400μM H2O2 (4h 
treatment + 20h incubation) or 200μM CoCl2 (24h) were transferred into wells 
containing naïve SMAD-Luciferase treated with and without SB-505124. A significant 
increase in luciferase activity (controlled by a SMAD promoter) was observed. H2O2 
and CoCl2 stimulated cell media compared to cells treated with SB-505124 (N=4). 
One-way ANOVA with Bonferroni method was used to analyse the data and graphs 
were plotted using prism 6 software. (**=p≤0.01, ***=p≤0.001, ****=p≤0.0001)   
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Cell transfer studies were performed to quantify active TGF-β production. Post 
stimulation with 400μM H2O2 (4h treatment + 20h incubation) or 200μM CoCl2 (24h), 
the inserts housing HKC8 cells were transferred onto naïve SMAD-Luciferase cells. 
Increased luciferase activity was seen in cells incubated with stimulated HKC8 cells 
(p≤0.001) compared to cells with control (Figure 4.20). 
 
Figure 4.20: SMAD-luciferase activity following cell transfer. Inserts containing 
HKC8 cells stimulated with H2O2 and CoCl2 were transferred onto naïve SMAD-
Luciferase cells for 24h. There was a significant (****=p≤0.0001) increase in 
luciferase activity post treatment with H2O2 or CoCl2 compared to control (N=3). One-
way ANOVA with Bonferroni method was used to analyse the data and graphs were 
plotted using prism 6 software. (****=p≤0.0001) 
4.3 Discussion  
TGF-β exerts a wide range of biological activities including its role in progression of 
renal fibrosis. Numerous studies have recognised proximal tubular epithelial cells as 
a potential source of TGF-β that may affect the renal morphology (Morrisey et al., 
2001). My data confirms that stimulation of proximal tubular epithelial cells with 
recombinant TGF-β1 led to acquisition of fibrotic spindle-shaped morphology along 
with a decrease in E-Cadherin expression and loss of cell-cell contact. Previous work 
by Tian et al demonstrated that stimulating HK-2 cells with 10ng/ml of recombinant 
TGF-β1 induced reorganisation of the actin cytoskeleton and the formation of dense 
focal adhesion plaques (Tian et al., 2003). Another study by Deyi luo et al showed 
that 3D colonies of HKC8 cells subjected to 10ng/ml TGF-β1 treatment showed an 
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increased cell movement due to appearance of finger-like pseudopodia (Luo et al., 
2017). Therefore, supporting data confirms that TGF-β1 induces phenotypic changes 
in fibrotic cells. 
There was a significant increase in α-SMA expression (1.6 fold) post TGF-β1 
treatment in HKC8 cells (Figure 4.2). This is consistent with a recent study that 
demonstrated an increased expression of MMP-2, FN-1 and TGF-β2 in TGF-β1 
stimulated HKC8 cells (Luo et al., 2017).  Protein studies using HKC8 (Figure 4.4) 
post TGF-β1 treatment exhibited a significant increase in α-SMA expression (5 fold) 
and reduced E-cadherin expression (9 fold). Similar trend was observed in HK2 cells. 
My results were in line with previous studies showing that TGF-β1 induces de novo 
transformation of epithelial cells to myofibroblast morphology orchestrated by loss of 
epithelial cell adhesion characteristics (Yang and Liu, 2001).    
The ALK-5 inhibitor was used to confirm the role of TGF-β in the changes that were 
observed (Byfield et al., 2004). My result demonstrated that, pre-treatment with ALK-
5 inhibitor blocked TGF-β mediated phenotypic changes in epithelial cells reducing α-
SMA whilst preserving E-cadherin expression.   
To investigate the role of TGF-β in ischemia and reperfusion injury, HKC8 cells were 
treated with the ALK5 inhibitor for 1 h followed by H2O2 and CoCl2 treatment. Pre-
treatment with ALK5 inhibitor prevented the changes induced by oxidative and 
hypoxic stress. This result implied a significant role of TGF-β in changes that occur in 
the renal tubular epithelium during IRI. This is also consistent with findings in 
pulmonary epithelium which undergo TGF-β- dependent EMT in response to free 
radical stress (Gorowiec et al., 2012). My study demonstrated that ALK5 inhibition 
blocked the changes induced by the hypoxic mimetic CoCl2. However, increased 
HIF-1α expression (30 fold) was seen in HKC8 cells pre-treated with ALK5 inhibition 
and stimulated with CoCl2 (Figure 4.9C).  
  
125 
 
To investigate whether TGF-β1 released by H2O2 or CoCl2 stimulated HKC8 cells 
could lead to fibrosis by stimulating fibroblast activity naïve MRC-5 cells were 
incubated with conditioned medium. Increased expression of α-SMA expression (2.2 
fold & 1.8 fold respectively) was observed in MRC-5 cells incubated with 
preconditioned media (acquired from stimulated HKC8 cells; Figure 4.11). In addition, 
MRC-5 cells pre-treated with ALK5 inhibitor prior to exposure to conditioned media 
did not show upregulation of myofibrotic markers.  
To mimic the in vivo cross talk and understand the role of PTEC derived TGF-β1 
production in the progression of fibrosis, an in vitro co-culture model consisting of 
HKC8 and MRC-5 cells was established. HKC8 cells were grown onto 3μM transwell 
inserts. Following stimulation with H2O2 or CoCl2, the inserts were transferred into a 
chamber with MRC-5 cells that were pre-treated with and without ALK5 inhibitor.  As 
with media transfer studies, ALK5 inhibitor treatment significantly reduced α-SMA 
expression at gene and protein level in H2O2 ( 1.5 & 4 fold decrease) or CoCl2 ( 2 & 
4.4 fold decrease)  treated MRC5 cells when compared to cells treated with H2O2 or 
CoCl2 only (Figure 4.13 & 4.14). A similar approach was adopted by Chiovaro et al to 
examine the role of TGF-β1 in inducing Tenascin W expression in BMSCs. MDA cells 
cultured in transwell inserts were transferred into BMSCs preincubated with and 
without ALK5 inhibitor. Increased Tenascin W expression was seen in BMSCs 
incubated with a transwell insert housing MDA cells. This expression was blocked in 
BMSCs preincubated with ALK5 inhibitor (Chiovaro et al., 2015). Investigating the 
effect of radiation on TGF-β/SMAD2 signalling, Xiaoming Yin et al performed co-
culture studies where keratinocytes cells cultured in transwell were pretreated with 
ALK5 inhibitor prior to irradiation. Following irradiation, HeCaT cell lines were co-
cultured with WS1 fibroblast cells. Protein studies confirm that WS1 cells pretreated 
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with ALK5 inhibitor prior to irradiation significantly inhibited pSMAD2 expression in 
WS1 cells (Yin et al., 2015).  
To assess active TGF-β production post ischaemia and reperfusion stress, SMAD-
luciferase assays were performed. Following H2O2 or CoCl2 treatment, cells released 
active TGF-β post that was coupled with increase in HIF-1α. Studies have shown that 
increase in HIF-1α further accelerates the production of TGF-β1 (Li et al., 2009; 
Heikkinen et al., 2010; Chaston et al., 2011; Jiao et al., 2015).  
In this study, inducing ischaemia using CoCl2 and reperfusion stress using oxidative 
free radicals leads to changes in HKC8 cells as observed in vivo during IRI. The 
results also provide conclusive evidence that changes induced in IRI are TGF-β 
mediated and that release of TGF-β by stressed cells during hypoxia and reperfusion 
could have detrimental consequences. For instance, its role in modulating fibroblast 
phenotype and promoting fibrosis has been well defined in myocardial infarction and 
cardiac remodelling (Frangogiannis, 2017) and hepatic IRI(Xu et al., 2016). 
Therefore, considering the significance of TGF-β-mediated actions in vivo, study of 
signalling pathways is needed to design strategies for effective blockage of TGF-β to 
protect against damage caused due to fibrosis.  
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Chapter 5: Blocking αvβ6 integrin protects epithelial cell 
phenotype post ischemia and reperfusion injury 
5.1 Introduction 
The first two results chapters of this thesis have already illustrated the role of active 
TGF-β in an in vitro model of IRI. It has previously been demonstrated that 
pharmacological blocking of TGF-β signaling pathway by treatment with an ALK5 
inhibitor significantly reduced pro-fibrotic marker expression in the presence of H2O2 
or CoCl2 (Section 4.4).  
αvβ6 integrin–dependent activation of latent TGF-β in pulmonary epithelial cells was 
proposed to be an underlying mechanism for experimental lung fibrosis (Kanwar, 
2012). Wang et al also demonstrated that the β6 integrin–null phenotype conferred 
protection from TGF-β–mediated hepatic fibrosis (Wang et al., 2007). Therefore, by 
eliminating the effects of αvβ6 integrin the profibrotic effects of TGF-β1 could be 
reduced. 
TGF-β1–mediated fibrosis has been proposed in a variety of human chronic kidney 
diseases that also exhibit increased αvβ6 integrin expression. This increase of αvβ6 
integrin could be due to TGF-β signalling (Hahm et al., 2007). This would mean that 
increased αvβ6 integrin expression and active TGF-β production form a positive self-
sustaining loop that reinforces TGF-β signalling. These data identify a novel 
mechanism for local regulation of TGF-β function in vivo by regulating expression of 
the αvβ6 integrin. Therefore, the the role of αvβ6 integrin in IRI was further 
investigated. 
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5.2 Results 
5.2.1 Effect of IRI on the expression of αvβ6 integrin expression  
Under normal conditions, epithelial cells do not express significant levels of Integrin 
αvβ6. To investigate αvβ6 integrin expression in proximal tubular epithelial cells post 
injury, HKC8 cells were treated with 200μM H2O2 (4 h+68 h) or 100μM CoCl2 (72 h). 
Post incubation, protein expression of αvβ6 integrin was examined by flow cytometry 
and immunofluorescence. Under resting condition, HKC8 cells did not express αvβ6 
integrin but expression was upregulated in response to stimulation with H2O2 and 
CoCl2. TGF-β1 treatment also increased the expression of αvβ6 integrin (Figure 5.1). 
In this experiment, TGF-β1 treated cells were used as a positive control. 
The expression of αvβ6 integrin was also analysed in HKC8 cells transfected with 
HIF-1α plasmid which leads to increased HIF-1α protein expression. Compared to 
the transfection control, overexpression of HIF-1α in HKC8 cells caused a detectable 
increase in αvβ6 integrin expression (Figure 5.2). A similar trend of expression was 
observed in HK-2 cells subjected to H2O2 and CoCl2 treatment compared to 
unstimulated control cells (Figure 5.3).   
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Figure 5.1: Increased αVβ6 expression in HKC8 cells.  
HKC8 cells stimulated with 200μM H2O2 (4h + 68h) or 100μM CoCl2 (72h) show an 
increased expression of αvβ6 integrin compared to control. Flow cytometry (A, N=2) 
and Immunofluorescence (B, N=1) studies were performed to study the expression at 
protein level. Images were taken at 400X magnification using Leica AF imaging unit. 
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Figure 5.2: Effect of overexpression of HIF-1α on αvβ6 integrin expression.  
Flow cytometry (A, N=2) and Immunofluorescence (B, N=1) show an increased 
expression of αvβ6 integrin in cells transfected with HIF-1α compared to control. 
Images were taken at 400X magnification for αVβ6 integrin using Leica AF imaging 
unit. 
 
 
Figure 5.3: Effect of CoCl2 or H2O2 on αVβ6 expression in HK-2 cells. HK-2 cells 
stimulated with 100μM H2O2 (4h + 68h) or 100μM CoCl2 (72h) displayed an increased 
expression of αvβ6 integrin compared to control (N=1). Images were taken at 400X 
magnification for αVβ6 integrin using Leica AF imaging unit. 
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5.2.2 Immunohistochemical analysis of αVβ6 integrin   
Immunohistochemical analysis was performed to examine the expression of αvβ6 
integrin in human kidney biopsies from patients with acute tubular necrosis. There 
was prominent αVβ6 integrin staining in the epithelial lining of the dilated and 
damaged (proximal and distal) tubules (Figure 5.4).  
To understand the dynamics of αVβ6 integrin expression in the kidneys of mice with 
IRI, immunohistochemical analysis of αVβ6 integrin expression was analysed in 
kidney early post IRI (25 mins ischaemia + 24 h reperfusion; n=7) and at a later stage 
(35 mins ischaemia + 28 days reperfusion; n=5). Mice sections were obtained from 
previous IRI study perfomed by Dr Anna Moles (Fearn et al., 2017). There was a 
significant increase in expression of αVβ6 in mouse kidney sections (early p≤0.001 
and late stage p≤0.05 of IRI) as compared to the control sections (Figure 5.5). 
 
Figure 5.4: αvβ6 integrin immunostaining in human kidney tissue. 
Paraffin embedded human kidney sections immunostained for αVβ6 integrin. An 
increased staining was evident in dilated and damaged tubules (B, n=11) compared 
to normal kidney (A, n=3). Photos were taken at 200X magnification using Leica AF 
imaging unit and are representative of images obtained from the other biopsy 
samples. 
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Figure 5.5: Immunohistochemical analysis of αvβ6 expression in mice 
following IRI. Paraffin embedded mouse kidney sections were immunostained for 
αVβ6. An increase in the expression of αVβ6 was observed in mouse kidney early 
post IRI (25 mins ischaemia + 24 h reperfusion; n=7) and at a later stage (35 mins 
ischaemia + 28 day reperfusion; n=5) as compared to the control (n=6). This 
persisted as fibrosis developed. Images (15 images/slide) were taken at 100X 
magnification for αVβ6 using Leica AF imaging unit. (*=p≤0.05)(**=p≤0.001) 
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5.2.3 The effect of ITGB6 sequence specific siRNA by HKC8 cells  
A αVβ6 integrin-blocking peptide was initially used to determine whether αVβ6 
integrin is involved in the regulation of TGF-β in IRI. However, since no significant 
difference in TGF-β activity was observed (Figure 2.8-1). Further experiments were 
performed using ITGB6 siRNA that suppresses β6 integrin activity (Section 2.6.1.1).  
HKC8 cells were transfected with sequence specific siRNA for ITGB6 at 
concentrations of 10nM, 30nM and 50nM or a control siRNA for 24 hours followed by 
stimulation with 10ng/ml of exogenous TGF-β1 for 48 h. Immunofluorescence 
staining and FACS data demonstrates that HKC8 cells stimulated with TGF-β1 
express αvβ6 integrin. Silencing of αvβ6 using 10nM, 30nM and 50nM of ITGB6 
specific siRNA induced a significant reduction in expression (Figure 5.6 A and B). 
Transfection of HKC8 cells with control siRNA (Csi) produced no significant effect on 
αvβ6 expression compared to stimulated, untransfected cells (Figure 5.6). RT-PCR 
data suggests that 10nM concentration can effectively block β6 expression upto 48 h 
post-TGF-β1 treatment compared to transfection control (Figure 5.7). 
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Figure 5.6: αvβ6 integrin expression in transfected HKC8 cells post TGF-β1 
treatment.  
HKC-8 cells were seeded and transfected with 10nM, 30nM and 50nM ITGB6 siRNA 
or a control siRNA (Csi) for 24h and then treated TGF-β1 for 48h. 
Immunofluorescence (A, N=1) and flow cytometry (B, N=2) studies were performed to 
study αvβ6 expression at protein level. Reduced αVβ6 expression was observed in 
HKC8 cells transfected with ITGB6 siRNA (10nM/30nM/50nM + TGF-β1) compared 
to corresponding control. Images were taken at 400X magnification for αvβ6 using 
Leica AF imaging unit.    
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Figure 5.7: ITGB6 sequence specific siRNA inhibits the expression of β6 mRNA 
Expression levels of β6 mRNA determined by qRT-PCR upon transfection with 
10nM, 30nM and 50nM ITGB6 siRNA or a control siRNA (Csi) for 24h followed by 
treatment with 10ng/ml of TGF-β1 for 48h. The experiment was normalised to 
18srRNA and expression levels compared to untreated control (A, N=1; B, N=3). 
Results indicate that TGF-β induces αvβ6 expression with largest effect at 10nM 
concentration. One-way Anova was used to analyse the data and graphs were 
plotted using Prism 6 software. (****=p≤0.0001) 
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5.2.4 Effect of αvβ6 knockdown on epithelial phenotype of HKC8 cells 
Previous data (Chapter 4) suggests the role of TGF-β in progression of fibrosis post 
IRI. I next assessed whether ECM component expression by PTEC post IRI can be 
manipulated by ITGB6 siRNA transfection in HKC8 cells. Confluent HKC8 cells were 
transiently transfected with 10nM ITGB6 sequence specific siRNA for 24h prior to 
treatment with 400μM H2O2 (4h+20h) or 200μM CoCl2 (24h). Cells transfected with 
control siRNA and stimulated with H2O2 or CoCl2 showed increased expression of α-
SMA and reduced E-cadherin expression. Introduction of ITGB6 siRNA preserved E-
cadherin expression (p≤0.001 and p≤0.0001) and curtailed expression of α-SMA 
expression (p≤0.0001 and p≤0.01) post stimulation (Figure 5.8-1 A and 5.8-2 A). The 
change in expression of E-Cadherin and α-SMA was further confirmed by Western 
blotting (Figure 5.8-1 B and 5.8-2 B). Silencing of αvβ6 integrin using 10nM of ITGB6 
sequence specific siRNA before treatment attenuated α-SMA expression and 
maintained E-cadherin expression. Transfection of HKC8 cells with control siRNA 
produced similar expression level compared to stimulated, untransfected cells. This 
suggests that ITGB6 siRNA, similar to SB-505124, maintains epithelial marker 
expression and reduces α-SMA expression post stimulation.  
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Figure 5.8-1: ITGB6 sequence specific siRNA decreases the expression of 
profibrotic markers in response to H2O2 in HKC8 cells. 
HKC-8 cells were transfected with 10nM of ITGB6 sequence specific siRNA or 
control siRNA (Csi) for 24h. Cells were treated with or without 400μM H2O2 for 24h. 
Immunofluorescence (A, N=3) and Western blotting (B) confirmed that ITGB6 
sequence specific siRNA preserves epithelial phenotype by maintaining E-cadherin 
expression and reducing α-SMA expression after stimulation, compared to non-
silencing control siRNA. One-way Anova Bonferroni method was used to analyse the 
data and graphs were plotted using Prism 6 software. Images were taken at 400X 
magnification for E-cadherin and α-SMA using Leica AF imaging unit. 
(****=p≤0.0001) 
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Figure 5.8-2: Knockdown of αvβ6 integrin in HKC8 cells decreases the 
expression of profibrotic markers in response to CoCl2. 
HKC-8 cells were transfected with 10nM of ITGB6 sequence specific siRNA or 
control siRNA (Csi) for 24h. Cells were treated with or without 200μM CoCl2 for 24h. 
Immunofluorescence (A, N=3) and Western blotting (B) confirmed that ITGB6 
sequence specific siRNA preserves epithelial phenotype by maintaining E-cadherin 
expression and reducing α-SMA expression after stimulation, compared to non-
silencing control siRNA. One-way Anova Bonferroni method was used to analyse the 
data and graphs were plotted using Prism 6 software. Images were taken at 400X 
magnification using Leica AF imaging unit. (**=p≤0.01, ***=p≤0.001, ****=p≤0.0001) 
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5.2.5 Transfection with ITGB6 sequence specific siRNA depletes 
active TGF-β bioavailability post CoCl2 and H2O2 treatment 
5.2.5.1 SMAD-Luciferase activity is reduced upon αvβ6 integrin knockdown 
Having demonstrated that blocking αvβ6 integrin reduced profibrotic maker 
expression in epithelial cells, SMAD-Luciferase assay was performed to ascertain 
that transient blocking of αvβ6 integrin could regulate active TGF-β production post 
CoCl2 and H2O2 treatment. HKC8 cells were transfected with ITGB6 sequence 
specific siRNA or control siRNA 24h prior to stimulation with 400μM H2O2 (4h+20h) 
or 200μM CoCl2 (24h). After 24h incubation, the conditioned media was collected and 
was transferred to SMAD-reporter HKC8 cells pretreated with or without 10μM ALK5 
inhibitor for 1h.    
Transfection of the ITGB6 siRNA resulted in abrogation of TGF-β induced luciferase 
activity (p≤0.05) that was evident when media was transferred from cells transfected 
with control siRNA. This induction of luciferase activity was not seen if the cells were 
pre-treated with SB505124 (Figure 5.9). These observations confirm that TGF-β is 
released following treatment with CoCl2 and H2O2 treatment and knockdown of αvβ6 
reduces active TGF-β bioavailability. 
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Figure 5.9: Silencing αvβ6 integrin minimizes active TGF- production post IRI.  
Conditioned media obtained from ITGB6 (10nM) or control siRNA (Csi) transfected 
HKC8 cells post stimulation were transferred to naïve HKC8 SMAD-reporter cells 
pre-treated with or without 10μM ALK5 inhibitor (S) for 1h (N=4). Treatment with 
ITGB6 siRNA (*=p≤0.05) reduced active TGF-β bioavailability in response to CoCl2 
and H2O2 treatment compared to control siRNA. One-way Anova Bonferroni method 
was used to analyse the data and graphs were plotted using Prism 6 software 
(****=p≤0.0001)  
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5.2.5.2 Co-culture model system 
Having developed an efficient co-culture system to replicate the in vivo environment, 
the following experiment was performed to assess whether knocking down the 
expression of αvβ6 integrin in PTEC can attenuate profibrotic changes induced in 
MRC5 cells post CoCl2 and H2O2 treatment. Conditioned media from HKC8 cells was 
transferred onto naïve MRC-5 cells and protein expression was assessed using 
Western blotting and immunofluorescence. Although a marked increase in α-SMA 
expression was observed in MRC-5 cells incubated with control siRNA transfected 
cell media, αvβ6 knockdown in HKC8 cells prior to stimulation lead to a significant 
reduction in TGF-β induced α-SMA expression in MRC-5 cells suggesting that αvβ6 
integrin has a functional effect on mechanisms that are recognised to mediate 
fibrosis (Figure 5.10).  
In addition to protein expression, expression of Fibronectin and α-SMA was assessed 
at mRNA level. αvβ6 integrin knockdown in HKC8 cells prior to stimulation and media 
transfer attenuated TGF-β induced expression of ECM associated genes in MRC-5 
cells , demonstrating that αvβ6 mediated activation of TGF-β can alter fibrosis though 
paracrine effects on surrounding cells (Figure 5.11). 
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Figure 5.10: Blocking of αvβ6 integrin reduces α-SMA expression in co-culture 
model. 
HKC8 cells were transfected with 10nM of ITGB6 sequence specific siRNA or control 
siRNA (Csi) for 24h and then treated with 400μM H2O2 or 200μM CoCl2 for 24h. 
Supernatants collected were transferred onto naïve MRC-5 cells. Protein studies 
involving Western blotting (N=2) and immunofluorescence (N=3) demonstrate that 
silencing αvβ6 integrin reduced α-SMA compared to control siRNA-treated cells. 
One-way Anova Bonferroni method was used to analyse the data and graphs were 
plotted using Prism 6 software. Images were taken at 400X magnification for α-SMA 
using Leica AF imaging unit. (****=p≤0.0001)    
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Figure 5.11: Blocking of αvβ6 integrin reduced expression of fibrotic gene 
expression. Gene expression of  α-SMA  and fibronectin was analysed in MRC-5 
cells post incubation with HKC8 cells transfected with ITGB6 (10nM) or control siRNA 
(Csi) and subjected to stimulation by 400μM H2O2 (4h+20h) or 200μM CoCl2  (24h). 
The experiment was normalised to 18srRNA (A and B, N=3). Inhibition of αvβ6 
integrin prior to stimulation abrogated the expression of α-SMA and fibronectin in 
MRC-5 cells when compared to MRC5 cells incubated with control siRNA transfected 
preconditioned media (Csi+H2O2 or Csi+ CoCl2).  One-way Anova Bonferroni method 
was used to analyse the data and graphs were plotted using Prism 6 software. 
(****=p≤0.0001)(***=p≤0.001) 
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5.3 Discussion 
Published data has demonstrated the role of αvβ6 integrin in disease and injury, 
however little is known about the contribution of αvβ6 integrin during IRI (Betensley et 
al., 2016; Song et al., 2016). The last part of my PhD work explored the contribution 
of αvβ6 integrin towards IRI and to determine whether blocking αvβ6 integrin could 
reduce the progression of fibrosis. αvβ6 integrin is expressed at relatively low levels 
in normal PTECs however, expression is increased during tissue remodeling, injury, 
and neoplasia (Okada and Kalluri, 2005). Cytokines such as EGF and TGF-β that 
regulate epithelial remodeling are capable of inducing an increased expression of the 
αvβ6 integrin in cultured epithelial cells (Hynes, 2002).  It has been shown that active 
TGF-β stimulation increases expression of αvβ6 integrin in a prostate cancer cell line 
suggesting that active TGF-β can stimulate αvβ6 expression in vitro (Dutta et al., 
2015).  
Activation of latent TGF-β by the αvβ6 integrin can only occur via direct association 
with the epithelial cells since αvβ6 integrin is an epithelial restricted integrin. This 
further leads to αvβ6 integrin binding to and activating TGF-β (Tatler et al., 2012). My 
IHC data shows an increased αvβ6 integrin expression in human renal biopsies with 
ATN. A previous study on human renal biopsies has shown that αvβ6 integrin is 
upregulated in distal tubules during acute rejection and end-stage chronic allograft 
nephropathy (Trevillian et al., 2004).     
αvβ6 integrin binds to the RGD domains on fibronectin, tenascin, the LAP1 and 3 and 
the N-terminal fragments of the latent precursor forms of TGF-β1.  Direct interaction 
between αvβ6 integrin and RGD motif contained within LAP1 and 3 converts TGF-β 
precursor into a receptor binding-competent state. Blocking RGD- domain prevents 
the subsequent binding of αvβ6 to the transforming growth factor-β1 latency-
associated peptide. However, mature TGF-β1 does not contain the RGD motif and 
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thus an additional ligand binding pocket distinct from RGD domain has been 
documented (Annes et al., 2002; Williams et al., 2004). For αvβ6, a non-RGD ligand 
recognition motif (DLXXL) has been described that is also detected on several 
proteins including collagen and fibrinogen. A sequence with 70% similarity to the 
recognition motif has also been detected in the LAP and mature TGF-β1(Kracklauer 
et al., 2003). In my study, DLXXL was used to block the binding of αvβ6 integrin and 
TGF-β1 and prevent the subsequent activation of mature TGF-β1. However, no 
significant change in active TGF-β production by HKC8 cells was observed.  
The use of siRNA technique has been reported in several studies where siRNA 
knockdown of αvβ6 significantly blocked the invasion of cancer cell line though 
matrigel compared to antibody mediated blocking (Niu et al., 2010; Moore et al., 
2014). In my study, I successfully silenced the expression of αvβ6 in HKC8 cells 
using sequence specific siRNA. Dutta et al made similar observations where 
silencing of αvβ6 integrin prior to 10ng/ml TGF-β1 stimulation did not increase αvβ6 
integrin in prostate cancer cells compared to non-transfected or cells transfected with 
a control siRNA (Dutta et al., 2015).  
The β6 knockdown model was used to assess the expression of epithelial and fibrotic 
markers post H2O2 and CoCl2 treatment. H2O2 or CoCl2 treated β6 knockdown HKC8 
cells preserved E-cadherin expression and reduced α-SMA expression compared to 
control siRNA cells. This result is supported by a mouse study where β6 knockout 
mice were protected from UUO induced tubulointerstitial fibrosis. These mice 
expressed low levels of collagen, PAI-1 and pSMAD2 at a protein and mRNA level 
compared to wild type (Ma et al., 2003).  
A SMAD-luciferase assay was performed to examine active TGF-β production in β6 
knockout cells. My data shows that transient knockdown of αvβ6 integrin reduces 
active TGF-β bioavailability in conditioned media. To mimic the in vivo effects of 
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blocking αvβ6 integrin on progression of fibrosis a co-culture system was used that 
showed reduced active TGF-β production, reduced α-SMA expression and fibroblast 
activation post αvβ6 blocking (Munger et al., 1999; Hahm et al., 2007; Allen et al., 
2014). I performed media transfer studies where results confirmed that αvβ6 integrin 
plays a major role in mediating TGF-β activation. Knockdown of αvβ6 blocked the 
paracrine auto-activation effect exhibited by TGF-β in mediating fibrosis.  
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Chapter 6: Discussion  
6.1 Specific aims and outcomes 
1. Establish an in vitro model of renal tubular IRI by using renal tubular proximal 
epithelial cell lines. 
The in vitro model of hypoxia and free radical stress established in this study allowed 
the investigation of the effects of IRI on proximal tubular epithelial cell phenotype. 
Various concentrations of hydrogen peroxide and cobalt chloride were used to induce 
free radical injury and hypoxia respectively.  This was followed by measurement of 
the expression of fibrotic markers such as α-SMA and the epithelial cell marker E-
Cadherin was studied using qRT-PCR, Western blotting and immunofluorescence in 
HKC8 and HK2 cells. Furthermore, the effect of hypoxia and free radical stress was 
also studied in lung fibroblast cells (MRC-5) with an aim to establish an in vitro 
system comprising epithelial cells and fibroblasts. Results suggested that H2O2 and 
CoCl2 induced oxidative stress and hypoxia in HKC8, HK2 and MRC-5 cells, 
increasing the expression of fibrotic markers and stimulating myofibroblast 
characteristics.  
2. Assess whether tubular cells develop a pro-fibrotic phenotype after IRI and 
determine whether these changes rely on the synthesis of intermediates such as 
TGF-β. 
Since TGF-β is implicated in mediating renal fibrosis, the effects of TGF-β on 
proximal tubular epithelial cells and fibroblasts were investigated at RNA and protein 
level. This was done by studying the changes in expression of epithelial and fibrotic 
markers. The effect of TGF-β on epithelial cell phenotype was also determined in the 
presence of a potent inhibitor of TGF-β signalling. SB-505124 blocked the effect of 
TGF-β1 on PTECs. ALK5 inhibition also prevented the changes induced by H2O2 and 
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CoCl2, retaining epithelial cell markers and inhibiting the expression of fibrotic 
markers. These results were in line with data from SB-505124 and TGF-β1 treated 
cells, suggesting the involvement of TGF-β in changes induced by CoCl2 and H2O2. 
This was further investigated in a co-culture system wherein media collected from 
H2O2 and CoCl2 stimulated HKC8 cells was transferred to wells containing MRC-5 
cells. This led to increased α-SMA expression which was inhibited in MRC-5 cells 
pre-treated with SB-505124. To confirm that stressed cells produce active TGF-β 
after stimulation that mimics IRI, HKC8 cells cultured in transwell were stimulated 
with H2O2 and CoCl2. The transwells were then transferred into wells containing naïve 
MRC-5 cells pre-treated with and without SB-505124. Transfer of stimulated cells led 
to an increase in α-SMA, a response that was inhibited by treatment with SB-505124. 
This suggests that bioactive TGF-β is released by HKC8 cells post IRI injury. 
3. Determining the role of αvβ6 integrin in IRI 
Since αvβ6 integrin regulates TGF-β activity, its role in IRI was investigated. Free 
radical stress and hypoxia increased the expression of αvβ6 integrin in vitro. Its 
expression in biopsy samples acquired form patients and mouse kidney following IRI 
was increased. Furthermore, the effect of αvβ6 integrin knockdown on epithelial 
responses was investigated using ITGB6 siRNA. Knockdown of αvβ6 integrin in 
HKC8 cells not only decreased the expression of profibrotic markers but also 
reduced the bioavailability of active TGF-β following CoCl2 and H2O2 treatment. This 
confirmed that bioactive TGF-β is produced following IRI and siRNA knockdown of 
αvβ6 integrin blocks its production. 
6.2 Overall discussion  
Data from this thesis has demonstrated a prominent role of TGF-β in kidney tubular 
epithelial cell responses post-IRI. Prior to the current study, investigation into injured 
PTECs has demonstrated that recovery of renal function is largely dependent on the 
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restoration of proximal tubular cells integrity and function. The repair mechanism in 
response to injury can lead to complete recovery (adaptive) or may lead to fibrosis 
and CKD (maladaptive). Adaptive repair is initially dependent on restoring the 
population of proximal tubular cells occurring 1 to 3 d post-injury (Tian and Phillips, 
2003; Humphreys et al., 2008). During maladaptive repair, epithelial cell cycle arrest 
and failure to repopulate the tubules can lead to fibrosis, thus providing a link 
between acute injury and CKD. This occurs when the injury is more severe, or 
repeated, and the stimulated cells cannot complete the cell cycle efficiently leading to 
arrest in the G2/M phase. Apoptosis of these cells is often blocked so that they 
survive and pro-fibrotic gene transcription is initiated. This repair process leads to 
incomplete structural and recovery  with accumulation of pro-fibrotic factors, 
increased production of extracellular matrix, and development of fibrosis (Yang et al., 
2010b). A study has demonstrated that moderate IRI is followed by repair without 
fibrosis, but severe IRI leads to fibrosis (Bonventre, 2014). Since one of the main 
causes of AKI is IRI, in this thesis an attempt to develop an in vitro model was 
undertaken to investigate the underlying mechanism involved in maladaptive repair 
and tissue fibrosis (Figure 5.12).  
Using an in vitro model instead of in vivo models has its benefits, as it allows the 
exact response of specific cells to be measured accurately. However, in vitro models 
have drawbacks as there is no assessment of the interaction between various cell 
types and some cells might show different behaviour in vitro than in vivo (Russ et al., 
2007). Nevertheless, well-designed in vitro models are crucial in understanding 
molecular mechanisms underlying disease and providing a foundation to subsequent 
in vivo work (Russ et al., 2007; Kurian and Pemaih, 2014). 
Previous studies have standardised in vitro cell based model of kidney IRI in rat 
(Williams et al., 1997) and mouse (Oxburgh and de Caestecker, 2012) tubular 
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proximal epithelial cells, renal epithelial cells of Hampshire pigs (Kurian and Pemaih, 
2014) and cultured human PTECs (Turman and Bates, 1997). HKC8 and HK2 have 
been used in in vitro models of IRI in this study. This is because culturing cell lines is 
much more efficient and less time consuming but may not maintain all features of the 
original cell than primary cells. Importantly it is the renal tubular epithelial cells that 
are most affected by IRI due to their high metabolic demands (Bonventre and 
Weinberg, 2003) 
 
Figure 5.12: Proposed model of IRI in human proximal epithelial cells. 
 
Ischaemia is associated with oxygen deprivation that leads to decline in ATP 
production and increase in HIF-1α stabilisation (Kurian and Pemaih, 2014). Several 
studies have used a hypoxic chamber to induce ischaemia in PTECs (Turman and 
Bates, 1997; Leonard et al., 2003; Xu et al., 2010; Ramamoorthy and Shi, 2014). 
Therefore, HKC8 cells were initially subjected to hypoxic conditions and the duration 
of incubation was optimised. CoCl2 was also used to replicate ischaemia as it has the 
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advantage to be inexpensive, fast and mimics hypoxia without the risk of hypoxia/re-
oxygenation as in the case of using hypoxic chambers (Wu and Yotnda, 2011; Dai et 
al., 2014).  HKC8 and HK2 cells, when treated with 100µM CoCl2, increase HIF-1α 
and developed a pro-fibrotic phenotype. Previous studies have reported similar 
induction of HIF-1α in Balb/c mice injected with CoCl2 (Zhang et al., 2014) and 
increased α-SMA expression in human coronary artery endothelial cells treated with 
CoCl2 (Xu et al., 2015).  
To induce free radical injury, HK2 and HKC8 cells were treated with H2O2 which is a 
source of ROS and implicated in renal IRI (Lee et al., 2013). H2O2 increased the 
expression of α–SMA and reduced E-Cadherin expression in HKC8 and HK2 cells. In 
vivo mice work has demonstrated that renal PTECs produce ROS during IRI and the 
extent of tubular damage correlates with H2O2  production (Wang et al., 2011).  
Hypoxia has been previously studied in mouse Embryonic Fibroblasts (Vengellur and 
LaPres, 2004), human dermal fibroblasts (Eleftheriadis et al., 2011) and human lung 
fibroblasts (MRC-5) (Mathieu et al., 2014) while ROS generation effects have been 
extensively studied in human dermal fibroblasts (Bladier et al., 1997) and MRC-5 
cells (Teramoto et al., 2001; Romeo et al., 2016). Due to unavailability of an 
appropriate human kidney fibroblast cell line, MRC-5 cells were used to study the 
effects of hypoxia and ROS in fibroblasts. Results showed a similar response as 
previously seen in HKC8 and HK2 cells following CoCl2 treatment. 
It has been recently reported that up-regulation of TGF-β and the downstream SMAD 
cascade is evident  in injured tubular epithelial cells arrested at the G2/M phase of 
cell cycle (Yang et al., 2010b). To study the progression of renal fibrosis post IRI, 
PTECs (HKC8 and HK2) were stimulated with TGF-β1. Changes in α-SMA and E-
Cadherin expression suggested a shift from an epithelial to fibrotic like phenotype as 
previously shown in an in vitro culture model of HKC8 cells (Phanish et al., 2006). 
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Several strategies have been proposed to inhibit TGF-β and enhance re-
epithelialization of cutaneous wounds and reduce scarring fibrosis. This includes the 
use of neutralising antibodies against TGF-β and small-molecule inhibitors for 
receptor serine/threonine kinases. While neutralising antibodies against TGF-β is the 
most intensively studied approach, the inhibitors of TGF-β signalling pathway 
developed for therapeutics are powerful tools in dissecting this complex pathway and 
studying the cross talk with other signalling pathways (Yanagita, 2012). In the 
present study, SB505124 which inhibits the TGF-β type I receptor serine/threonine 
kinase (ALK5 inhibitor) , was used (Byfield et al., 2004). The effect of ALK5 inhibition 
was not only apparent in TGF-β treated HKC8 cells but also on IRI induced changes. 
The latter was done to ascertain that the changes in epithelial cell phenotype 
observed post IRI are mediated by TGF‐β (Kapoor et al., 2016). 
Epithelial cells can control and regulate fibroblast phenotype and both primary cells 
and cell lines are being used in different culture matrices and co-culture models (Moll 
et al., 2013). To study the interaction between epithelial cells and fibroblasts, an in 
vitro model comprising of HKC8 and MRC-5 cells was established. Here, MRC-5 
cells were incubated with H2O2 and CoCl2 pre-conditioned media (from HKC8 cells) 
and the expression of fibrotic markers was assessed in the presence and absence of 
SB505124. Increase in fibrotic markers was observed in cells stimulated only with the 
preconditioned media suggesting fibroblast activation. Similar results were reported 
when media from Cisplastin treated HKC8 cells increased level of key fibrotic 
markers α-SMA, TGF- β1 and Collagen 1α1 in WS-1 dermal fibroblasts (Moll et al., 
2013). Additionally, SB505124 prevented effects of HKC8 preconditioned media on 
MRC-5 cells. This suggests that stressed epithelial cells produce active TGF-β post 
IRI insult (Geng et al., 2009). This was confirmed by stimulating HKC8 cells grown in 
transwell inserts with H2O2 and CoCl2 prior to transferring the cell into wells containing 
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MRC-5 cells. Under these conditions α-SMA expression in MRC-5 cells was 
increased. SB505124 inhibited this change. This was also validated using luciferase 
assay studies (Section 4.5). 
There are sequences within the β6 subunit of αvβ6 integrin that bind the LAP 
(Munger et al., 1999). Subsequently, cell culture studies showed that fibroblasts and 
epithelial cells can use integrins to activate latent TGF-β (Wipff et al., 2007; 
Giacomini et al., 2012). Since αvβ6 integrin is implicated in TGF-β induced 
pulmonary fibrosis (M Teoh et al., 2015), the role of αvβ6 integrin was investigated in 
renal IRI.  
Stimulating HKC8 cells with H2O2 and CoCl2 resulted in an increase of αvβ6 integrin. 
This could be due to the fact that active TGF-β production by virtue of cell activation 
due to H2O2 and CoCl2 results in upregulation of TGF-β which increases αvβ6 integrin 
that then leads to a positive feedback loop in TGF-β signalling (Cagle, 2010 434). 
Furthermore high expression of αvβ6 integrin was also demonstrated in patients and 
mouse kidney tissue (acute IRI and chronic IRI model) as previously reported 
(Trevillian et al., 2004). Subsequently, using sequence specific siRNA for αvβ6 
integrin in HKC8 cells prior to stimulation with H2O2 and CoCl2 not only reduced the 
expression of profibrotic marker expression but also reduced TGF-β bioavailability. 
Similar results were observed in co-culture model (Section 5.2.5.2). This model 
established an in vitro system to replicate the in vivo effects of αvβ6 integrin in the 
progression of fibrosis. 
6.2 Conclusion 
In this study an in vitro and co-culture model was established. The in vitro model was 
designed to stimulate both phases of IRI whereas the co-culture model allowed 
studying the downstream effects of stressed epithelial cells on fibroblasts. The model 
was also able to examine the repair period post IRI that involves TGF-β signalling. 
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Lastly the use of ALK5 inhibitor and αvβ6 siRNA suggests that TGF-β has a 
significant role to play in the progression of renal fibrosis post IRI. 
6.3 Limitations 
Gene expression profile of fibrotic markers did not yield similar results as seen in 
protein studies. The reason for this is unclear. Furthermore, only key experiments 
could be replicated in HK2 cells as they were only available during the last year of my 
study. MRC-5 cells were used due to unavailability of a human renal fibroblast cell 
line. 
Although several attempts were made to optimise the concentration and protocol for 
Western blotting using HIF-1α, this could not be performed due to excessive 
background staining. An attempt to create stable transfectants (HKC8 cells) 
overexpressing HIF-1α (for co-culture model) also failed due to excessive cell death. 
I also attempted to use collagen gels concentration to generate co-culture beds. 
However, the fibroblast cells failed to proliferate and lead to poor RNA quality and 
inconsistent gene expression profiling. Lastly, αvβ6 blocking peptides were used prior 
to using αvβ6 siRNA. However, αvβ6 blocking peptides had no effect on TGF-β 
production. 
6.4 Future directions 
Future work would emphasis on the use of β6 integrin knockout mice to study the 
progression of TGF-β induced renal fibrosis post IRI. This would involve examining 
the expression of fibrotic markers in epithelial cells and adjacent fibroblasts post 
inducing acute and chronic IRI in β6 integrin knockout mice versus wildtype mice. 
Furthermore, pharmacological blocking of αVβ6 integrin using inhibitor peptides in 
mice would allow validating whether inhibition of αVβ6 integrin could alter the renal 
microenvironment during both homeostasis and IRI leading to reduced renal injury 
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and improved survival. Lastly, the role of αVβ6 integrin as a biomarker of renal 
fibrosis would be evaluated in cells derived from patient urine. 
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